<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Conjugated estrogens</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Premarin">
  <link href="../-/s/css_modules/mediawiki.action.view.redirectPage.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.action.view.redirectPage.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Conjugated estrogens</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Conjugated estrogens</b> (<b>CEs</b>), or <b>conjugated equine estrogens</b> (<b>CEEs</b>), sold under the brand name <b>Premarin</b> among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications.<span class="mw-ref" id="cite_ref-Martindale_5-0"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-PremarinLabel_3-4"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-3"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-0"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is a mixture of the <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate.<span class="mw-ref" id="cite_ref-pmid16112947_1-4"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-1"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_5-1"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations.<span class="mw-ref" id="cite_ref-MoscouSnipe2012_7-0"><a href="#cite_note-MoscouSnipe2012-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-HumansOrganization2007_8-0"><a href="#cite_note-HumansOrganization2007-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> They are formulated both alone and in combination with progestins such as <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>.<span class="mw-ref" id="cite_ref-Martindale_5-2"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle.<span class="mw-ref" id="cite_ref-pmid16112947_1-5"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Drugs@FDA_2-1"><a href="#cite_note-Drugs@FDA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>



<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Conjugated estrogens</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Estrone_sulfate.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Estrone_sulfate.svg.png" data-file-width="512" data-file-height="268" data-file-type="drawing" height="118" width="225"></figure-inline><div>Estrone sulfate, the primary active component in conjugated estrogens (constitutes about 50 to 70% of total content).</div></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Equilin_sulfate.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Equilin_sulfate.svg.png" data-file-width="512" data-file-height="268" data-file-type="drawing" height="118" width="225"></figure-inline><div>Equilin sulfate, the second most major active component in conjugated estrogens (constitutes about 20 to 30% of total content).</div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Combination of</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Estrone sulfate</th><td>Estrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Equilin sulfate</th><td>Estrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">17α-Dihydro-equilin sulfate</th><td>Estrogen</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Cenestin, Enjuvia, Congest, C.E.S., Premarin, Prempro (with <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate"><abbr>MPA</abbr></a>), Premphase (with <abbr>MPA</abbr>), others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>CEs; Conjugated equine estrogens; CEEs; Pregnant mares' urine; Premarin; Estrogens, conjugated</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/cdi/premarin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cdi/premarin.html'" tppabs="https://www.drugs.com/cdi/premarin.html" class="external text external">Consumer Drug Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>X</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, topical, vaginal, intravenous injection, intramuscular injection<span class="mw-ref" id="cite_ref-pmid16112947_1-0"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Drugs@FDA_2-0"><a href="#cite_note-Drugs@FDA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Estrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03CA57<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03CA57  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03CA57'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03CA57" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>Variable<span class="mw-ref" id="cite_ref-PremarinLabel_3-0"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>High (to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a> and <abbr>SHBG</abbr>)<span class="mw-ref" id="cite_ref-PremarinLabel_3-1"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-1"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver<span class="mw-ref" id="cite_ref-PremarinLabel_3-2"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-2"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>Estrone: 26.7 hours<br>Estrone (<abbr>BA</abbr>): 14.8 hours<br><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a>: 11.4 hours<span class="mw-ref" id="cite_ref-DrugBank_4-0"><a href="#cite_note-DrugBank-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine<span class="mw-ref" id="cite_ref-PremarinLabel_3-3"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=12126-59-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=12126-59-9'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=12126-59-9" class="external text external">12126-59-9</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/656613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/656613'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/656613" class="external text external">656613</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem<span> </span><span style="font-weight:normal"><abbr>SID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505680'" tppabs="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505680" class="external text external">46505680</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.570974.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.570974.html'" tppabs="http://www.chemspider.com/Chemical-Structure.570974.html" class="external text external">570974</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=IU5QR144QX  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=IU5QR144QX'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=IU5QR144QX" class="external text external">IU5QR144QX</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D04070  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D04070'" tppabs="https://www.kegg.jp/entry/D04070" class="external text external">D04070</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID00860005,  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID00860005,'" tppabs="https://comptox.epa.gov/dashboard/DTXSID00860005," class="external text external">DTXSID70881181 DTXSID00860005, DTXSID70881181</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.006.475  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.006.475'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.006.475" class="external text external">100.006.475</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=455284681&page2=Conjugated+estrogens  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=455284681&page2=Conjugated+estrogens'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=455284681&page2=Conjugated+estrogens" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Side effects of CEEs include breast tenderness and enlargement, headache, fluid retention, and nausea among others.<span class="mw-ref" id="cite_ref-PremarinLabel_3-5"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-6"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may increase the risk of endometrial hyperplasia and endometrial cancer in women with an intact uterus if it is not taken together with a progestogen like progesterone.<span class="mw-ref" id="cite_ref-PremarinLabel_3-6"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-7"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The medication may also increase the risk of blood clots, cardiovascular disease, and, when combined with most progestogens, breast cancer.<span class="mw-ref" id="cite_ref-pmid28664754_9-0"><a href="#cite_note-pmid28664754-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> CEEs are estrogens, or agonists of the estrogen receptor, the biological target of <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogens</a> like <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>.<span class="mw-ref" id="cite_ref-pmid16112947_1-8"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-PremarinLabel_3-7"><a href="#cite_note-PremarinLabel-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Compared to estradiol, certain estrogens in CEEs are more resistant to metabolism, and the medication shows relatively increased effects in certain parts of the body like the liver.<span class="mw-ref" id="cite_ref-pmid16112947_1-9"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This results in an increased risk of blood clots and cardiovascular disease with CEEs relative to estradiol.<span class="mw-ref" id="cite_ref-pmid16112947_1-10"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid25223916_10-0"><a href="#cite_note-pmid25223916-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


<p>Premarin, the major brand of CEEs in use, is manufactured by Wyeth and was first marketed in 1941 in Canada and in 1942 in the United States.<span class="mw-ref" id="cite_ref-FritzSperoff2012_6-2"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is the most commonly used form of estrogen in menopausal hormone therapy in the United States.<span class="mw-ref" id="cite_ref-pmid24176763_11-0"><a href="#cite_note-pmid24176763-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Quereda2017_12-0"><a href="#cite_note-Quereda2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> However, it has begun to fall out of favor relative to bioidentical estradiol, which is the most widely used form of estrogen in Europe for menopausal hormone therapy.<span class="mw-ref" id="cite_ref-Quereda2017_12-1"><a href="#cite_note-Quereda2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-pmid28301216_13-0"><a href="#cite_note-pmid28301216-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-pmid24398406_14-0"><a href="#cite_note-pmid24398406-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-pmid19179815_15-0"><a href="#cite_note-pmid19179815-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> CEEs are available widely throughout the world.<span class="mw-ref" id="cite_ref-Martindale_5-3"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> An estrogen preparation very similar to CEEs but differing in source and composition is esterified estrogens.<span class="mw-ref" id="cite_ref-pmid16112947_1-11"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> In 2017, it was the 206th most commonly prescribed medication in the United States, with more than two million prescriptions.<span class="mw-ref" id="cite_ref-DrugStats2017_16-0"><a href="#cite_note-DrugStats2017-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>CEEs are a form of hormone therapy used in women.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> It is used most commonly in postmenopausal women who have had a hysterectomy to treat hot flashes, and burning, itching, and dryness of the vagina and surrounding areas.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It must be used in combination with a progestogen in women who have not had a hysterectomy.<span class="mw-ref" id="cite_ref-pmid16112947_1-12"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> For women already taking the medication, it can be used to treat osteoporosis, although it is not recommended solely for this use.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Some lesser known uses are as a means of high-dose estrogen therapy in the treatment of breast cancer in both women and men and in the treatment of prostate cancer in men.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> It has been used at a dosage of 2.5<span>&nbsp;</span>mg three times per day (7.5<span>&nbsp;</span>mg/day total) for prostate cancer.<span class="mw-ref" id="cite_ref-OettelSchillinger2012_23-0"><a href="#cite_note-OettelSchillinger2012-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-DenisGriffiths1999_24-0"><a href="#cite_note-DenisGriffiths1999-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>CEEs are specifically approved in countries such as the United States and Canada for the treatment of moderate to severe vasomotor symptoms (hot flashes) and vulvovaginal atrophy (atrophic vaginitis, atrophic urethritis) associated with menopause, hypoestrogenism due to hypogonadism, ovariectomy, or primary ovarian failure, abnormal uterine bleeding, the palliative treatment of metastatic breast cancer in women, the palliative treatment of advanced androgen-dependent prostate cancer in men, and the prevention of postmenopausal osteoporosis.<span class="mw-ref" id="cite_ref-DrugBank_4-1"><a href="#cite_note-DrugBank-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com-Premarin_25-0"><a href="#cite_note-Drugs.com-Premarin-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_5-4"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The intravenous formulation of CEEs is specifically used to rapidly limit bleeding in women with hemorrhage due to dysfunctional uterine bleeding.<span class="mw-ref" id="cite_ref-Drugs@FDA_2-2"><a href="#cite_note-Drugs@FDA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-HorskyPresl1981_26-0"><a href="#cite_note-HorskyPresl1981-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>318</span></sup><span class="mw-ref" id="cite_ref-Piersol1975_27-0"><a href="#cite_note-Piersol1975-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>60</span></sup></p>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Estrogen dosages for menopausal hormone therapy</caption>
<tbody><tr>
<th>Route/form</th><th>Estrogen</th><th>Low</th><th>Standard</th><th>High</th></tr>
<tr>
<td rowspan="8">Oral</td><td>Estradiol</td><td>0.5–1 mg/day</td><td>1–2 mg/day</td><td>2–4 mg/day</td></tr>
<tr>
<td>Estradiol valerate</td><td>0.5–1 mg/day</td><td>1–2 mg/day</td><td>2–4 mg/day</td></tr>
<tr>
<td>Estradiol acetate</td><td>0.45–0.9 mg/day</td><td>0.9–1.8 mg/day</td><td>1.8–3.6 mg/day</td></tr>
<tr>
<td>Conjugated estrogens</td><td>0.3–0.45 mg/day</td><td>0.625 mg/day</td><td>0.9–1.25 mg/day</td></tr>
<tr>
<td>Esterified estrogens</td><td>0.3–0.45 mg/day</td><td>0.625 mg/day</td><td>0.9–1.25 mg/day</td></tr>
<tr>
<td>Estropipate</td><td>0.75 mg/day</td><td>1.5 mg/day</td><td>3 mg/day</td></tr>
<tr>
<td>Estriol</td><td>1–2 mg/day</td><td>2–4 mg/day</td><td>4–8 mg/day</td></tr>
<tr>
<td>Ethinylestradiol<sup>a</sup></td><td>2.5 μg/day</td><td>5–15 μg/day</td><td>–</td></tr>
<tr>
<td>Nasal spray</td><td>Estradiol</td><td>150 μg/day</td><td>300 μg/day</td><td>600 μg/day</td></tr>
<tr>
<td>Transdermal patch</td><td>Estradiol</td><td>25 μg/day<sup>b</sup></td><td>50 μg/day<sup>b</sup></td><td>100 μg/day<sup>b</sup></td></tr>
<tr>
<td>Transdermal gel</td><td>Estradiol</td><td>0.5 mg/day</td><td>1–1.5 mg/day</td><td>2–3 mg/day</td></tr>
<tr>
<td rowspan="2">Vaginal</td><td>Estradiol</td><td>25 μg/day</td><td>–</td><td>–</td></tr>
<tr>
<td>Estriol</td><td>30 μg/day</td><td>0.5 mg 2x/week</td><td>0.5 mg/day</td></tr>
<tr>
<td rowspan="3"><abbr>IM</abbr> or <abbr>SC</abbr> injection</td><td>Estradiol valerate</td><td>–</td><td>–</td><td>4 mg 1x/4 weeks</td></tr>
<tr>
<td>Estradiol cypionate</td><td>1 mg 1x/3–4 weeks</td><td>3 mg 1x/3–4 weeks</td><td>5 mg 1x/3–4 weeks</td></tr>
<tr>
<td>Estradiol benzoate</td><td>0.5 mg 1x/week</td><td>1 mg 1x/week</td><td>1.5 mg 1x/week</td></tr>
<tr>
<td><abbr>SC</abbr> implant</td><td>Estradiol</td><td>25 mg 1x/6 months</td><td>50 mg 1x/6 months</td><td>100 mg 1x/6 months</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = No longer used or recommended, due to health concerns. <sup>b</sup> = As a single patch applied once or twice per week (worn for 3–4 days or 7 days), depending on the formulation. <b>Note:</b> Dosages are not necessarily equivalent. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Estrogen dosages for breast cancer</caption>
<tbody><tr>
<th>Route/form</th><th>Estrogen</th><th>Dosage</th></tr>
<tr>
<td rowspan="8">Oral</td><td>Estradiol</td><td>10 mg 3x/day<br><i><abbr>AI</abbr>-resistant:</i> 2 mg 1–3x/day</td></tr>
<tr>
<td>Estradiol valerate</td><td><i><abbr>AI</abbr>-resistant:</i> 2 mg 1–3x/day</td></tr>
<tr>
<td>Conjugated estrogens</td><td>10 mg 3x/day</td></tr>
<tr>
<td>Ethinylestradiol</td><td>0.5–1 mg 3x/day</td></tr>
<tr>
<td><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></td><td>5 mg 3x/day</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>5 mg 3x/day</td></tr>
<tr>
<td>Dimestrol</td><td>30 mg/day</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>24 mg/day</td></tr>
<tr>
<td rowspan="5"><abbr>IM</abbr> or <abbr>SC</abbr> injection</td><td>Estradiol benzoate</td><td>5 mg 2–3x/week</td></tr>
<tr>
<td>Estradiol dipropionate</td><td>5 mg 2–3x/week</td></tr>
<tr>
<td>Estradiol valerate</td><td>30 mg 1x/2 weeks</td></tr>
<tr>
<td>Polyestradiol phosphate</td><td>40–80 mg 1x/4 weeks</td></tr>
<tr>
<td>Estrone</td><td>5 mg ≥3x/week</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Only in women who are at least 5<span>&nbsp;</span>years postmenopausal. (2) Dosages are not necessarily equivalent. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Estrogen dosages for prostate cancer</caption>
<tbody><tr>
<th>Route/form</th><th>Estrogen</th><th>Dosage</th></tr>
<tr>
<td rowspan="11">Oral</td><td>Estradiol</td><td>1–2 mg 3x/day</td></tr>
<tr>
<td>Conjugated estrogens</td><td>1.25–2.5 mg 3x/day</td></tr>
<tr>
<td>Ethinylestradiol</td><td>0.15–3 mg/day</td></tr>
<tr>
<td>Ethinylestradiol sulfonate</td><td>1–2 mg 1x/week</td></tr>
<tr>
<td><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></td><td>1–3 mg/day</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>5 mg/day</td></tr>
<tr>
<td>Hexestrol</td><td>5 mg/day</td></tr>
<tr>
<td><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol</a></td><td>100–480 mg 1–3x/day</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>12–48 mg/day</td></tr>
<tr>
<td>Quadrosilan</td><td>900 mg/day</td></tr>
<tr>
<td>Estramustine phosphate</td><td>140–1400 mg/day</td></tr>
<tr>
<td>Transdermal patch</td><td>Estradiol</td><td>2–6x 100 μg/day<br><i>Scrotal:</i> 1x 100 μg/day</td></tr>
<tr>
<td rowspan="6"><abbr>IM</abbr> or <abbr>SC</abbr> injection</td><td>Estradiol benzoate</td><td>1.66 mg 3x/week</td></tr>
<tr>
<td>Estradiol dipropionate</td><td>5 mg 1x/week</td></tr>
<tr>
<td>Estradiol valerate</td><td>10–40 mg 1x/1–2 weeks</td></tr>
<tr>
<td>Estradiol undecylate</td><td>100 mg 1x/4 weeks</td></tr>
<tr>
<td>Polyestradiol phosphate</td><td><i>Alone:</i> 160–320 mg 1x/4 weeks<br><i>With oral <abbr>EE</abbr>:</i> 40–80 mg 1x/4 weeks</td></tr>
<tr>
<td>Estrone</td><td>2–4 mg 2–3x/week</td></tr>
<tr>
<td rowspan="2"><abbr>IV</abbr> injection</td><td><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol</a></td><td>300–1200 mg 1–7x/week</td></tr>
<tr>
<td>Estramustine phosphate</td><td>240–450 mg/day</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Note:</b> Dosages are not necessarily equivalent. <b>Sources:</b> See template.</td></tr>
</tbody></table>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    


<p>Natural CEEs, as Premarin, are available in the form of oral tablets (0.3<span>&nbsp;</span>mg, 0.625<span>&nbsp;</span>mg, 0.9<span>&nbsp;</span>mg, 1.25<span>&nbsp;</span>mg, or 2.5<span>&nbsp;</span>mg), creams for topical or vaginal administration (0.625<span>&nbsp;</span>mg/g), and vials for intravenous or intramuscular injection (25<span>&nbsp;</span>mg/vial).<span class="mw-ref" id="cite_ref-Drugs@FDA_2-3"><a href="#cite_note-Drugs@FDA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-MorleyBerg1999_28-0"><a href="#cite_note-MorleyBerg1999-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> Synthetic CEEs, such as Cenestin, Enjuvia, and generic formulations, are available in the form of oral tablets (0.3<span>&nbsp;</span>mg, 0.45<span>&nbsp;</span>mg, 0.625<span>&nbsp;</span>mg, 0.9<span>&nbsp;</span>mg, or 1.25<span>&nbsp;</span>mg) and creams for topical or vaginal administration (0.625<span>&nbsp;</span>mg/g).<span class="mw-ref" id="cite_ref-Drugs@FDA_2-4"><a href="#cite_note-Drugs@FDA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Shorr2007_29-0"><a href="#cite_note-Shorr2007-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    


<p>Contraindications of CEEs include breast cancer and a history of venous thromboembolism, among others.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>The most common side effects associated with CEEs are vaginal yeast infections, vaginal spotting or bleeding, painful menses, and cramping of the legs. While there are some contradictory data, estrogen alone does not appear to increase the risk of coronary heart disease or breast cancer, unlike the case of estrogen in combination with certain progestins such as <a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">levonorgestrel</a> or <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Only a few clinical studies have assessed differences between oral CEEs and oral estradiol in terms of health parameters.<span class="mw-ref" id="cite_ref-pmid26327865_31-0"><a href="#cite_note-pmid26327865-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Oral CEEs have been found to possess a significantly greater risk of thromboembolic and cardiovascular complications than oral estradiol (<abbr>OR</abbr> = 2.08) and oral esterified estrogens (<abbr>OR</abbr> = 1.78).<span class="mw-ref" id="cite_ref-pmid26327865_31-1"><a href="#cite_note-pmid26327865-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid24081194_32-0"><a href="#cite_note-pmid24081194-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid15467060_33-0"><a href="#cite_note-pmid15467060-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> However, in another study, the increase in venous thromboembolism risk with oral CEEs plus medroxyprogesterone acetate and oral estradiol plus norethisterone acetate was found to be equivalent (<abbr>RR</abbr> = 4.0 and 3.9, respectively).<span class="mw-ref" id="cite_ref-pmid27998619_34-0"><a href="#cite_note-pmid27998619-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid23136837_35-0"><a href="#cite_note-pmid23136837-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> As of present, there are no randomized controlled trials that would allow for unambiguous conclusions.<span class="mw-ref" id="cite_ref-pmid26327865_31-2"><a href="#cite_note-pmid26327865-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="font-size: small; margin-left: auto; margin-right: auto; border: none; text-align:center;">
<caption class="nowrap"> <span style="font-family:sans-serif;font-size:105%;color:black;background-color:transparent;;">Results of the Women's Health Initiative (WHI) menopausal hormone therapy randomized controlled trials</span></caption>
<tbody><tr><th rowspan="2">Clinical outcome</th>
<th rowspan="2">Hypothesized <br>effect on risk</th>
<th colspan="3">Estrogen and progestogen<br>(<abbr>CEs</abbr> 0.625<span>&nbsp;</span>mg/day p.o. + <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate"><abbr>MPA</abbr></a> 2.5<span>&nbsp;</span>mg/day p.o.)<br>(n = 16,608, with uterus, 5.2–5.6 years follow up)</th>
<th colspan="3">Estrogen alone<br>(<abbr>CEs</abbr> 0.625<span>&nbsp;</span>mg/day p.o.)<br>(n = 10,739, no uterus, 6.8–7.1 years follow up)</th></tr>
<tr>
<th width="100px"><abbr>HR</abbr></th>
<th width="100px">95% <abbr>CI</abbr></th>
<th width="100px"><abbr>AR</abbr></th>
<th width="100px"><abbr>HR</abbr></th>
<th width="100px">95% <abbr>CI</abbr></th>
<th width="100px "><abbr>AR</abbr></th></tr>
<tr>
<td style="text-align: left;">Coronary heart disease</td>
<td>Decreased</td>
<td style="background: #ffcccb;">1.24</td>
<td>1.00–1.54</td>
<td style="background: #ffcccb;">+6 / 10,000 PYs</td>
<td style="background: #cffbd4;">0.95</td>
<td>0.79–1.15</td>
<td style="background: #cffbd4;">−3 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Stroke</td>
<td>Decreased</td>
<td style="background: #ffcccb;">1.31</td>
<td>1.02–1.68</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.37</td>
<td>1.09–1.73</td>
<td style="background: #ffcccb;">+12 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Pulmonary embolism</td>
<td>Increased</td>
<td style="background: #ffcccb;">2.13</td>
<td>1.45–3.11</td>
<td style="background: #ffcccb;">+10 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.37</td>
<td>0.90–2.07</td>
<td style="background: #ffcccb;">+4 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Venous thromboembolism</td>
<td>Increased</td>
<td style="background: #ffcccb;">2.06</td>
<td>1.57–2.70</td>
<td style="background: #ffcccb;">+18 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.32</td>
<td>0.99–1.75</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Breast cancer</td>
<td>Increased</td>
<td style="background: #ffcccb;">1.24</td>
<td>1.02–1.50</td>
<td style="background: #ffcccb;">+8 / 10,000 PYs</td>
<td style="background: #cffbd4;">0.80</td>
<td>0.62–1.04</td>
<td style="background: #cffbd4;">−6 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Colorectal cancer</td>
<td>Decreased</td>
<td style="background: #cffbd4;">0.56</td>
<td>0.38–0.81</td>
<td style="background: #cffbd4;">−7 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.08</td>
<td>0.75–1.55</td>
<td style="background: #ffcccb;">+1 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Endometrial cancer</td>
<td>–</td>
<td style="background: #cffbd4;">0.81</td>
<td>0.48–1.36</td>
<td style="background: #cffbd4;">−1 / 10,000 PYs</td>
<td>–</td>
<td>–</td>
<td>–</td></tr>
<tr>
<td style="text-align: left;">Hip fractures</td>
<td>Decreased</td>
<td style="background: #cffbd4;">0.67</td>
<td>0.47–0.96</td>
<td style="background: #cffbd4;">−5 / 10,000 PYs</td>
<td style="background: #cffbd4;">0.65</td>
<td>0.45–0.94</td>
<td style="background: #cffbd4;">−7 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Total fractures</td>
<td>Decreased</td>
<td style="background: #cffbd4;">0.76</td>
<td>0.69–0.83</td>
<td style="background: #cffbd4;">−47 / 10,000 PYs</td>
<td style="background: #cffbd4;">0.71</td>
<td>0.64–0.80</td>
<td style="background: #cffbd4;">−53 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Total mortality</td>
<td>Decreased</td>
<td style="background: #cffbd4;">0.98</td>
<td>0.82–1.18</td>
<td style="background: #cffbd4;">−1 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.04</td>
<td>0.91–1.12</td>
<td style="background: #ffcccb;">+3 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Global index</td>
<td>–</td>
<td style="background: #ffcccb;">1.15</td>
<td>1.03–1.28</td>
<td style="background: #ffcccb;">+19 / 10,000 PYs</td>
<td style="background: #ffcccb;">1.01</td>
<td>1.09–1.12</td>
<td style="background: #ffcccb;">+2 / 10,000 PYs</td></tr>
<tr>
<td style="text-align: left;">Diabetes</td>
<td>–</td>
<td style="background: #cffbd4;">0.79</td>
<td>0.67–0.93</td>
<td></td>
<td style="background: #cffbd4;">0.88</td>
<td>0.77–1.01</td>
<td></td></tr>
<tr>
<td style="text-align: left;">Gallbladder disease</td>
<td>Increased</td>
<td style="background: #ffcccb;">1.59</td>
<td>1.28–1.97</td>
<td></td>
<td style="background: #ffcccb;">1.67</td>
<td>1.35–2.06</td>
<td></td></tr>
<tr>
<td style="text-align: left;">Stress incontinence</td>
<td>–</td>
<td style="background: #ffcccb;">1.87</td>
<td>1.61–2.18</td>
<td></td>
<td style="background: #ffcccb;">2.15</td>
<td>1.77–2.82</td>
<td></td></tr>
<tr>
<td style="text-align: left;">Urge incontinence</td>
<td>–</td>
<td style="background: #ffcccb;">1.15</td>
<td>0.99–1.34</td>
<td></td>
<td style="background: #ffcccb;">1.32</td>
<td>1.10–1.58</td>
<td></td></tr>
<tr>
<td style="text-align: left;">Peripheral artery disease</td>
<td>–</td>
<td style="background: #cffbd4;">0.89</td>
<td>0.63–1.25</td>
<td></td>
<td style="background: #ffcccb;">1.32</td>
<td>0.99–1.77</td>
<td></td></tr>
<tr>
<td style="text-align: left;">Probable dementia</td>
<td>Decreased</td>
<td style="background: #ffcccb;">2.05</td>
<td>1.21–3.48</td>
<td></td>
<td style="background: #ffcccb;">1.49</td>
<td>0.83–2.66</td>
<td></td></tr>
<tr>
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Abbreviations:</b> CEs = conjugated estrogens. MPA = <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>. p.o. = per oral. HR = hazard ratio. AR = attributable risk. PYs = person–years. CI = confidence interval.  <b>Notes:</b> Sample sizes (n) include placebo recipients, which were about half of patients. "Global index" is defined for each woman as the time to earliest diagnosis for coronary heart disease, stroke, pulmonary embolism, breast cancer, colorectal cancer, endometrial cancer (estrogen plus progestogen group only), hip fractures, and death from other causes. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"> Risk of venous thromboembolism (VTE) with hormone therapy and birth control (QResearch/CPRD)</caption>
<tbody><tr>
<th class="unsortable">Type</th><th class="unsortable">Route</th><th class="unsortable">Medications</th><th>Odds ratio (95% <abbr>CI</abbr>)</th></tr>
<tr>
<td rowspan="14">Menopausal hormone therapy</td><td rowspan="10">Oral</td><td>Estradiol alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day</td><td>1.27 (1.16–1.39)*<br>1.22 (1.09–1.37)*<br>1.35 (1.18–1.55)*</td></tr>
<tr>
<td>Conjugated estrogens alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤0.625<span>&nbsp;</span>mg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;0.625<span>&nbsp;</span>mg/day</td><td>1.49 (1.39–1.60)*<br>1.40 (1.28–1.53)*<br>1.71 (1.51–1.93)*</td></tr>
<tr>
<td>Estradiol/medroxyprogesterone acetate</td><td>1.44 (1.09–1.89)*</td></tr>
<tr>
<td>Estradiol/dydrogesterone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day <abbr>E2</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day <abbr>E2</abbr></td><td>1.18 (0.98–1.42)<br>1.12 (0.90–1.40)<br>1.34 (0.94–1.90)</td></tr>
<tr>
<td>Estradiol/norethisterone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤1<span>&nbsp;</span>mg/day <abbr>E2</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;1<span>&nbsp;</span>mg/day <abbr>E2</abbr></td><td>1.68 (1.57–1.80)*<br>1.38 (1.23–1.56)*<br>1.84 (1.69–2.00)*</td></tr>
<tr>
<td>Estradiol/norgestrel or estradiol/drospirenone</td><td>1.42 (1.00–2.03)</td></tr>
<tr>
<td>Conjugated estrogens/medroxyprogesterone acetate</td><td>2.10 (1.92–2.31)*</td></tr>
<tr>
<td>Conjugated estrogens/norgestrel<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤0.625<span>&nbsp;</span>mg/day <abbr>CEEs</abbr><br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;0.625<span>&nbsp;</span>mg/day <abbr>CEEs</abbr></td><td>1.73 (1.57–1.91)*<br>1.53 (1.36–1.72)*<br>2.38 (1.99–2.85)*</td></tr>
<tr>
<td>Tibolone alone</td><td>1.02 (0.90–1.15)</td></tr>
<tr>
<td><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a> alone</td><td>1.49 (1.24–1.79)*</td></tr>
<tr>
<td rowspan="3">Transdermal</td><td>Estradiol alone<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>≤50<span>&nbsp;</span>μg/day<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>&gt;50<span>&nbsp;</span>μg/day</td><td>0.96 (0.88–1.04)<br>0.94 (0.85–1.03)<br>1.05 (0.88–1.24)</td></tr>
<tr>
<td>Conjugated estrogens alone</td><td>1.04 (0.76–1.43)</td></tr>
<tr>
<td>Estradiol/progestogen</td><td>0.88 (0.73–1.01)</td></tr>
<tr>
<td rowspan="1">Vaginal</td><td>Estradiol alone</td><td>0.84 (0.73–0.97)</td></tr>
<tr>
<td rowspan="7">Combined birth control</td><td rowspan="7">Oral</td><td>Ethinylestradiol/norethisterone</td><td>2.56 (2.15–3.06)*</td></tr>
<tr>
<td>Ethinylestradiol/levonorgestrel</td><td>2.38 (2.18–2.59)*</td></tr>
<tr>
<td>Ethinylestradiol/norgestimate</td><td>2.53 (2.17–2.96)*</td></tr>
<tr>
<td>Ethinylestradiol/desogestrel</td><td>4.28 (3.66–5.01)*</td></tr>
<tr>
<td>Ethinylestradiol/gestodene</td><td>3.64 (3.00–4.43)*</td></tr>
<tr>
<td>Ethinylestradiol/drospirenone</td><td>4.12 (3.43–4.96)*</td></tr>
<tr>
<td>Ethinylestradiol/cyproterone acetate</td><td>4.27 (3.57–5.11)*</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Nested case–control studies (2015, 2019) based on data from the QResearch and Clinical Practice Research Datalink (CPRD) databases. (2) Bioidentical progesterone was not included, but is known to be associated with no additional risk relative to estrogen alone. <b>Footnotes:</b> * = Statistically significant (<i>p</i> &lt; 0.01). <b>Sources</b>: See template.</td></tr>
</tbody></table>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    


<p>Estrogens, including CEEs, are relatively safe in acute overdose.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    


<p>Inhibitors and inducers of cytochrome P450 enzymes may interact with CEEs.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    


<div class="thumb tright"><div class="thumbinner" style="width:227px"><img src="../I/m/Estradiol.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Estradiol.svg.png" data-file-width="512" data-file-height="324" data-file-type="drawing" height="142" width="225"><div class="thumbcaption" style="text-align: left">Estradiol, the main active form of estrone sulfate and the major active estrogen with CEEs.<span class="mw-ref" id="cite_ref-pmid16112947_1-13"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></div></div></div>

<div class="thumb tright"><div class="thumbinner" style="width:227px"><img src="../I/m/17β-Dihydroequilin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/17%CE%B2-Dihydroequilin.svg.png" data-file-width="1170" data-file-height="780" data-file-type="drawing" height="150" width="225"><div class="thumbcaption" style="text-align: left">17β-Dihydroequilin, the main active form of equilin sulfate and the second major active estrogen with CEEs.<span class="mw-ref" id="cite_ref-pmid16112947_1-14"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></div></div></div>

<p>CEEs are a combination of estrogens, or agonists of the estrogen receptors.<span class="mw-ref" id="cite_ref-pmid16112947_1-15"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The major estrogen in CEEs, sodium estrone sulfate, itself is inactive, and rather serves as a prodrug of estrone and then of estradiol.<span class="mw-ref" id="cite_ref-pmid16112947_1-16"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Buchsbaum2012_36-0"><a href="#cite_note-Buchsbaum2012-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-FalconeHurd2013_37-0"><a href="#cite_note-FalconeHurd2013-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> The transformation of estrone sulfate to estrone is catalyzed by steroid sulfatase, and of estrone into estradiol by 17β-hydroxysteroid dehydrogenase.<span class="mw-ref" id="cite_ref-pmid16112947_1-17"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Sanfilippo1998_38-0"><a href="#cite_note-Sanfilippo1998-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> CEEs (as Premarin) and estrone have been found to be equivalent in potency in an animal model of estrogenic activity.<span class="mw-ref" id="cite_ref-FritzSperoff2012_6-3"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> On the other hand, the active forms of the equine estrogens in CEEs, such as <a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">equilin</a> and 17β-dihydroequilin, have greater potency in the liver relative to bioidentical estradiol, similarly to synthetic estrogens like ethinylestradiol and <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>.<span class="mw-ref" id="cite_ref-pmid16112947_1-18"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This results in disproportionate effects on liver protein production compared to estradiol, although to a lesser extent than ethinylestradiol and diethylstilbestrol.<span class="mw-ref" id="cite_ref-pmid16112947_1-19"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> In addition, 17β-dihydroequilenin has shown a selective estrogen receptor modulator (SERM)-like profile of estrogenic activity in studies with monkeys, in which beneficial effects on bone and the cardiovascular system were observed but proliferative responses in breast or endometrium were not seen, although the clinical significance of this is unknown.<span class="mw-ref" id="cite_ref-pmid17443713_39-0"><a href="#cite_note-pmid17443713-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>CEEs consists of the <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> salts of the sulfate esters of equine estrogens in a specific and consistent composition (see the table).<span class="mw-ref" id="cite_ref-pmid16112947_1-20"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-4"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The major estrogens in CEEs are sodium estrone sulfate and sodium equilin sulfate, which together account for approximately 71.5 to 92.0% of the total content of CEEs.<span class="mw-ref" id="cite_ref-Martindale_5-5"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-pmid16112947_1-21"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-5"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> CEEs are prodrugs of the active forms of the estrogens.<span class="mw-ref" id="cite_ref-pmid16112947_1-22"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-6"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_5-6"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Sodium estrone sulfate is a prodrug of estrone, which in turn is a prodrug of estradiol, while sodium equilin sulfate is a prodrug of <a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">equilin</a> and then of 17β-dihydroequilin.<span class="mw-ref" id="cite_ref-pmid16112947_1-23"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> As such, the major active estrogens with CEEs are estradiol and 17β-dihydroequilin, which have potent estrogenic activity and account for most of the effects of CEEs.<span class="mw-ref" id="cite_ref-pmid16112947_1-24"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The 17α-estrogens in CEEs such as 17α-estradiol and 17α-dihydroequilin have low estrogenicity and are thought to contribute minimally to its effects.<span class="mw-ref" id="cite_ref-pmid16112947_1-25"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> There are many different steroids in natural CEE products like Premarin, as many as 230<span>&nbsp;</span>compounds and including even androgens and progestogens, but only the estrogens are present in sufficient amounts to produce clinically-relevant effects.<span class="mw-ref" id="cite_ref-FritzSperoff2012_6-7"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid16915215_40-0"><a href="#cite_note-pmid16915215-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid24176763_11-1"><a href="#cite_note-pmid24176763-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>A dosage of 0.625<span>&nbsp;</span>mg/day oral CEEs has been found to increase SHBG levels by 100%.<span class="mw-ref" id="cite_ref-pmid16915215_40-1"><a href="#cite_note-pmid16915215-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid10914617_41-0"><a href="#cite_note-pmid10914617-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> For comparison, 1<span>&nbsp;</span>mg/day oral estradiol increased SHBG levels by 45%, while 50<span>&nbsp;</span>µg/day transdermal estradiol increased SHBG levels by 12%.<span class="mw-ref" id="cite_ref-pmid16915215_40-2"><a href="#cite_note-pmid16915215-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid10914617_41-1"><a href="#cite_note-pmid10914617-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Ethinylestradiol is more potent in its effects on liver protein synthesis than either CEEs or estradiol, with 10<span>&nbsp;</span>µg/day oral ethinylestradiol having been found to be approximately equivalent to 1.25<span>&nbsp;</span>mg/day CEEs.<span class="mw-ref" id="cite_ref-pmid16915215_40-3"><a href="#cite_note-pmid16915215-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Composition of conjugated estrogens and properties of constituents</caption>
<tbody><tr>
<th>Compound</th><th>Synonym</th><th data-sort-type="number">Proportion (%)</th><th>Relative potency<br>in the vagina (%)</th><th data-sort-type="number">Relative potency<br>in the uterus (%)</th><th data-sort-type="number"><abbr>RBA</abbr> for<br>ERα (%)</th><th data-sort-type="number"><abbr>RBA</abbr> for<br>ERβ (%)</th><th data-sort-type="number">ERα / ERβ<br><abbr>RBA</abbr> ratio</th></tr>
<tr>
<td>Conjugated estrogens</td><td>–</td><td>100</td><td>38</td><td>100</td><td>–</td><td>–</td><td>–</td></tr>
<tr>
<td>Estrone</td><td>–</td><td>49.1–61.5</td><td>30</td><td>32</td><td>26</td><td>52</td><td>0.50</td></tr>
<tr>
<td><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></td><td>Δ<sup>7</sup>-Estrone</td><td>22.4–30.5</td><td>42</td><td>80</td><td>13</td><td>49</td><td>0.26</td></tr>
<tr>
<td>17α-Dihydroequilin</td><td>Δ<sup>7</sup>-17α-Estradiol</td><td>13.5–19.5</td><td>0.06</td><td>2.6</td><td>41</td><td>32</td><td>1.30</td></tr>
<tr>
<td>17α-Estradiol</td><td>–</td><td>2.5–9.5</td><td>0.11</td><td>3.5</td><td>19</td><td>42</td><td>0.45</td></tr>
<tr>
<td>Δ<sup>8</sup>-Estrone</td><td>–</td><td>3.5–3.9</td><td>?</td><td>?</td><td>19</td><td>32</td><td>0.60</td></tr>
<tr>
<td><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></td><td>Δ<sup>6,8</sup>-Estrone</td><td>2.2–2.8</td><td>1.3</td><td>11.4</td><td>15</td><td>20–29</td><td>0.50–0.75</td></tr>
<tr>
<td>17β-Dihydroequilin</td><td>Δ<sup>7</sup>-17β-Estradiol</td><td>0.5–4.0</td><td>83</td><td>200</td><td>113</td><td>108</td><td>1.05</td></tr>
<tr>
<td>17α-Dihydroequilenin</td><td>Δ<sup>6,8</sup>-17α-Estradiol</td><td>1.2–1.6</td><td>0.018</td><td>1.3</td><td>20</td><td>49</td><td>0.40</td></tr>
<tr>
<td>17β-Estradiol</td><td>–</td><td>0.56–0.9</td><td>100</td><td>?</td><td>100</td><td>100</td><td>1.00</td></tr>
<tr>
<td>17β-Dihydroequilenin</td><td>Δ<sup>6,8</sup>-17β-Estradiol</td><td>0.5–0.7</td><td>0.21</td><td>9.4</td><td>68</td><td>90</td><td>0.75</td></tr>
<tr>
<td>Δ<sup>8</sup>-17β-Estradiol</td><td>–</td><td data-sort-value="0">Small amounts</td><td>?</td><td>?</td><td>68</td><td>72</td><td>0.94</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> All listed compounds are present in conjugated estrogen products specifically in the form of the <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> salts of the sulfate esters (i.e., as sodium estrone sulfate, sodium equilin sulfate, etc.). <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"> Oral potencies of estrogens</caption>
<tbody><tr>
<th>Estrogen</th><th>Type</th><th>Class</th><th class="unsortable"><abbr>ETD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>EPD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>MSD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>MSD</abbr><br><small>(daily)</small></th><th class="unsortable"><abbr>OID</abbr><br><small>(daily)</small></th><th class="unsortable"><abbr>TSD</abbr><br><small>(daily)</small></th></tr>
<tr>
<td>Estradiol (non-micronized)</td><td>Bioidentical</td><td>Steroidal</td><td>30 mg</td><td>≥120–300 mg</td><td>120 mg</td><td>6 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Estradiol (micronized)</td><td>Bioidentical</td><td>Steroidal</td><td>6–12 mg</td><td>60–80 mg</td><td>14–42 mg</td><td>1–2 mg</td><td>&gt;5 mg</td><td>&gt;8 mg</td></tr>
<tr>
<td>Estradiol valerate</td><td>Bioidentical</td><td>Steroidal</td><td>6–12 mg</td><td>60–80 mg</td><td>14–42 mg</td><td>1–2 mg</td><td>?</td><td>&gt;8 mg</td></tr>
<tr>
<td>Estradiol benzoate</td><td>Bioidentical</td><td>Steroidal</td><td>?</td><td>60–140 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Estriol</td><td>Bioidentical</td><td>Steroidal</td><td>20 mg<sup>a</sup></td><td>120–150 mg<sup>b</sup></td><td>28–126 mg</td><td>1–6 mg</td><td>&gt;5 mg</td><td>?</td></tr>
<tr>
<td>Estriol succinate</td><td>Bioidentical</td><td>Steroidal</td><td>?</td><td>140–150 mg<sup>b</sup></td><td>28–126 mg</td><td>2–6 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Estrone sulfate</td><td>Bioidentical</td><td>Steroidal</td><td>12 mg</td><td>60 mg</td><td>42 mg</td><td>2 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Conjugated estrogens</td><td>Natural</td><td>Steroidal</td><td>5–12 mg</td><td>60–80 mg</td><td>8.4–25 mg</td><td>0.625–1.25 mg</td><td>&gt;3.75 mg</td><td>7.5 mg</td></tr>
<tr>
<td>Ethinylestradiol</td><td>Synthetic</td><td>Steroidal</td><td>200 μg</td><td>1–2 mg</td><td>280 μg</td><td>20–40 μg</td><td>100 μg</td><td>100 μg</td></tr>
<tr>
<td><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></td><td>Synthetic</td><td>Steroidal</td><td>300 μg</td><td>1.5–3.0 mg</td><td>300–600 μg</td><td>25–30 μg</td><td>&gt;80 μg</td><td>?</td></tr>
<tr>
<td><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></td><td>Synthetic</td><td>Steroidal</td><td>300 μg</td><td>2–4 mg</td><td>500 μg</td><td>25–50 μg</td><td>?</td><td>?</td></tr>
<tr>
<td>Methylestradiol</td><td>Synthetic</td><td>Steroidal</td><td>?</td><td>2 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>2.5 mg</td><td>20–30 mg</td><td>11 mg</td><td>0.5–2.0 mg</td><td>&gt;5 mg</td><td>3 mg</td></tr>
<tr>
<td>Diethylstilbestrol dipropionate</td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>15–30 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>5 mg</td><td>30–40 mg</td><td>42 mg</td><td>0.5–4.0 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Dienestrol diacetate</td><td>Synthetic</td><td>Nonsteroidal</td><td>3–5 mg</td><td>30–60 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Hexestrol</td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>70–110 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>&gt;100 mg</td><td>?</td><td>?</td><td>&gt;48 mg</td><td>?</td></tr>
<tr>
<td><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>400 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr class="sortbottom">
<td colspan="9" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Very variable, often higher. <sup>b</sup> = In divided doses, 3x/day; irregular and atypical proliferation. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table style="margin-left: auto; margin-right: auto; border: none;" class="wikitable sortable mw-collapsible mw-collapsed">
<caption class="nowrap"> Relative oral potencies of estrogens</caption>
<tbody><tr>
<th>Estrogen</th><th>Type</th><th data-sort-type="number"><abbr>HF</abbr></th><th data-sort-type="number"><abbr>VE</abbr></th><th data-sort-type="number"><abbr>UCa</abbr></th><th data-sort-type="number"><abbr>FSH</abbr></th><th data-sort-type="number"><a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a></th><th data-sort-type="number"><abbr>HDL</abbr>-<a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol"><abbr>C</abbr></a></th><th data-sort-type="number"><abbr>SHBG</abbr></th><th data-sort-type="number"><abbr>CBG</abbr></th><th data-sort-type="number"><abbr>AGT</abbr></th><th data-sort-type="number"><abbr>Liver</abbr></th></tr>
<tr>
<td>Estradiol</td><td>Bioidentical</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td></tr>
<tr>
<td>Estrone</td><td>Bioidentical</td><td>?</td><td>?</td><td>?</td><td>0.3</td><td>0.3</td><td>?</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Estriol</td><td>Bioidentical</td><td>0.3</td><td>0.3</td><td>0.1</td><td>0.3</td><td>0.3</td><td>0.2</td><td>?</td><td>?</td><td>?</td><td>0.67</td></tr>
<tr>
<td>Estrone sulfate</td><td>Bioidentical</td><td>?</td><td>0.9</td><td>0.9</td><td>0.8–0.9</td><td>0.9</td><td>0.5</td><td>0.9</td><td>0.5–0.7</td><td>1.4–1.5</td><td>0.56–1.7</td></tr>
<tr>
<td>Conjugated estrogens</td><td>Natural</td><td>1.2</td><td>1.5</td><td>2.0</td><td>1.1–1.3</td><td>1.0</td><td>1.5</td><td>3.0–3.2</td><td>1.3–1.5</td><td>5.0</td><td>1.3–4.5</td></tr>
<tr>
<td>Equilin sulfate</td><td>Natural</td><td>?</td><td>?</td><td>1.0</td><td>?</td><td>?</td><td>6.0</td><td>7.5</td><td>6.0</td><td>7.5</td><td>?</td></tr>
<tr>
<td>Ethinylestradiol</td><td>Synthetic</td><td>120</td><td>150</td><td>400</td><td>60–150</td><td>100</td><td>400</td><td>500–600</td><td>500–600</td><td>350</td><td>2.9–5.0</td></tr>
<tr>
<td><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></td><td>Synthetic</td><td>?</td><td>?</td><td>?</td><td>2.9–3.4</td><td>?</td><td>?</td><td>26–28</td><td>25–37</td><td>20</td><td>5.7–7.5</td></tr>
<tr class="sortbottom">
<td colspan="12" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are ratios, with estradiol as standard (i.e., 1.0). <b>Abbreviations:</b> <abbr>HF</abbr> = Clinical relief of hot flashes. <abbr>VE</abbr> = Increased proliferation of vaginal epithelium. <abbr>UCa</abbr> = Decrease in <abbr>UCa</abbr>. <abbr>FSH</abbr> = Suppression of <abbr>FSH</abbr> levels. <abbr>LH</abbr> = Suppression of <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a> levels. <abbr>HDL</abbr>-<abbr>C</abbr>, <abbr>SHBG</abbr>, <abbr>CBG</abbr>, and <abbr>AGT</abbr> = Increase in the serum levels of these liver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (specifically hot flashes relief and gonadotropin suppression). <b>Type:</b> Bioidentical = Identical to those found in humans. Natural = Naturally occurring but not identical to those found in humans (e.g., estrogens of other species). Synthetic = Man-made, does not occur naturally in animals or in the environment. <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antigonadotropic_effects">Antigonadotropic effects</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Testosterone_levels_with_different_estrogen_therapies_in_men_with_prostate_cancer.png" tppabs="https://ptable.com/wiki/compounds/I/m/Testosterone_levels_with_different_estrogen_therapies_in_men_with_prostate_cancer.png" data-file-width="2046" data-file-height="1348" data-file-type="bitmap" height="198" width="300"><div class="thumbcaption" style="text-align: left">Testosterone levels with no treatment and with various estrogens in men with prostate cancer.<span class="mw-ref" id="cite_ref-pmid4359746_42-0"><a href="#cite_note-pmid4359746-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Determinations were made with an early radioimmunoassay (RIA).<span class="mw-ref" id="cite_ref-pmid4359746_42-1"><a href="#cite_note-pmid4359746-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Source was Shearer et al. (1973).<span class="mw-ref" id="cite_ref-pmid4359746_42-2"><a href="#cite_note-pmid4359746-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></div></div></div>

<p>A preliminary study of ovulation inhibition in women found that oral CEEs was 33% effective at 1.25<span>&nbsp;</span>mg/day and 94% at 3.75<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-Greenblatt1966_43-0"><a href="#cite_note-Greenblatt1966-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-HerrRevesz1970_44-0"><a href="#cite_note-HerrRevesz1970-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> A dosage of oral CEEs of 2.5<span>&nbsp;</span>mg three times daily (7.5<span>&nbsp;</span>mg/day total) has been found to suppress total testosterone levels in men to an equivalent extent as 3<span>&nbsp;</span>mg/day oral <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, which is the minimum dosage of diethylstilbestrol required to consistently suppress total testosterone levels into the castrate range (&lt;50<span>&nbsp;</span>ng/dL).<span class="mw-ref" id="cite_ref-pmid29603164_45-0"><a href="#cite_note-pmid29603164-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    


<p>CEEs are hydrolyzed in the intestines during first-pass metabolism upon oral administration.<span class="mw-ref" id="cite_ref-pmid8842581_46-0"><a href="#cite_note-pmid8842581-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_5-7"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Following their absorption, they are resulfated mainly in the liver also during the first pass.<span class="mw-ref" id="cite_ref-pmid8842581_46-1"><a href="#cite_note-pmid8842581-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> Following this, they serve as a circulating reservoir and are slowly rehydrolyzed into their unconjugated active forms.<span class="mw-ref" id="cite_ref-pmid8842581_46-2"><a href="#cite_note-pmid8842581-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>

<p>Oral CEEs, at a daily dosage of 0.625<span>&nbsp;</span>mg, achieve estrone and estradiol levels of 150<span>&nbsp;</span>pg/mL and 30–50<span>&nbsp;</span>pg/mL, respectively, while a daily oral dosage of 1.25<span>&nbsp;</span>mg achieves levels of 120–200<span>&nbsp;</span>pg/mL and 40–60<span>&nbsp;</span>pg/mL of estrone and estradiol, respectively.<span class="mw-ref" id="cite_ref-Lobo2007_47-0"><a href="#cite_note-Lobo2007-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> The oral ingestion of 10<span>&nbsp;</span>mg<span>&nbsp;</span>CEEs, which contains about 4.5<span>&nbsp;</span>mg sodium estrone sulfate and 2.5<span>&nbsp;</span>mg sodium equilin sulfate, produces maximal plasma concentrations of estrone and equilin of 1,400<span>&nbsp;</span>pg/mL and 560<span>&nbsp;</span>pg/mL within 3 and 5<span>&nbsp;</span>hours, respectively.<span class="mw-ref" id="cite_ref-Lobo2007_47-1"><a href="#cite_note-Lobo2007-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> By 24<span>&nbsp;</span>hours post-dose of 10<span>&nbsp;</span>mg, the levels of estrone and equilin fall to 280<span>&nbsp;</span>pg/mL and 125<span>&nbsp;</span>pg/mL, respectively.<span class="mw-ref" id="cite_ref-Lobo2007_47-2"><a href="#cite_note-Lobo2007-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> Oral CEEs 1.25<span>&nbsp;</span>mg/daily and oral micronized estradiol 1<span>&nbsp;</span>mg/daily result in similar plasma concentrations of estrone and estradiol (150–300<span>&nbsp;</span>pg/mL and 30–50<span>&nbsp;</span>pg/mL for micronized estradiol, respectively) (oral estradiol is extensively metabolized into estrone during hepatic first-pass metabolism),<span class="mw-ref" id="cite_ref-Lobo2007_47-3"><a href="#cite_note-Lobo2007-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> although this does not account for equilin and other equine estrogens involved in the effects of CEEs, which may be significantly more potent in comparison to estrone.<span class="mw-ref" id="cite_ref-NotelovitzKeep2012_48-0"><a href="#cite_note-NotelovitzKeep2012-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span><span class="mw-ref" id="cite_ref-Seidel1974_49-0"><a href="#cite_note-Seidel1974-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> The pharmacokinetics of vaginal CEEs have been studied as well.<span class="mw-ref" id="cite_ref-pmid7231202_50-0"><a href="#cite_note-pmid7231202-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>

<p>Extremely high concentrations of equilin are produced by typical clinical dosages of CEEs.<span class="mw-ref" id="cite_ref-WallachHammond1982_51-0"><a href="#cite_note-WallachHammond1982-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> With a dosage of 1.25<span>&nbsp;</span>mg oral CEEs, equilin levels of 1,082 to 2,465<span>&nbsp;</span>pg/mL have been observed.<span class="mw-ref" id="cite_ref-WallachHammond1982_51-1"><a href="#cite_note-WallachHammond1982-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> The clinical significance of these levels of equilin is unknown.<span class="mw-ref" id="cite_ref-WallachHammond1982_51-2"><a href="#cite_note-WallachHammond1982-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p>The active forms are metabolized primarily in the liver.<span class="mw-ref" id="cite_ref-Martindale_5-8"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> There is some enterohepatic recirculation of CEEs.<span class="mw-ref" id="cite_ref-Martindale_5-9"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Following a single oral dose of 0.625<span>&nbsp;</span>CEEs, the biological half-life of estrone was 26.7<span>&nbsp;</span>hours, of baseline-adjusted estrone was 14.8<span>&nbsp;</span>hours, and of equilin was 11.4<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-DrugBank_4-2"><a href="#cite_note-DrugBank-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Plasma estrogen levels after a single dose of conjugated estrogens by different routes</caption>
<tbody><tr>
<th>Route</th><th>Dose</th><th><abbr>Time</abbr></th><th><abbr>E2</abbr> (<abbr>↑Δ</abbr>)</th><th><abbr>E1</abbr> (<abbr>↑Δ</abbr>)</th><th><abbr>Ratio</abbr></th></tr>
<tr>
<td>Oral<br><span>&nbsp;</span></td><td>0.3 mg<br>0.625 mg<br>1.25 mg<br>1.25 mg<br>2.5 mg</td><td>6 hours<br>6 hours<br>6 hours<br>1 hour<br>6 hours</td><td>+20 pg/mL<br>+50 pg/mL<br>+70 pg/mL<br>+35–58 pg/mL<br>+160 pg/mL</td><td><abbr>ND</abbr><br><abbr>ND</abbr><br><abbr>ND</abbr><br>110 pg/mL<br><abbr>ND</abbr></td><td><abbr>ND</abbr><br><abbr>ND</abbr><br><abbr>ND</abbr><br>0.32–0.52<br><abbr>ND</abbr></td></tr>
<tr>
<td>Vaginal<br>(cream)</td><td>0.3 mg<br>0.625 mg<br>0.625 mg<br>1.25 mg<br>1.25 mg<br>2.5 mg</td><td><abbr>ND</abbr><br><abbr>ND</abbr><br><abbr>ND</abbr><br>2 hours<br><abbr>ND</abbr><br><abbr>ND</abbr></td><td>+4 pg/mL<br>+13–29 pg/mL<br>+17 pg/mL<br>+25 pg/mL<br>+27 pg/mL<br>+32 pg/mL</td><td>+20 pg/mL<br>+29–55 pg/mL<br>+45 pg/mL<br>+50 pg/mL<br>+110 pg/mL<br>+40 pg/mL</td><td>0.2<br>0.24–1.0<br>0.38<br>0.5<br>0.25<br>0.8</td></tr>
<tr>
<td>Intravenous</td><td>25 mg</td><td><abbr>ND</abbr></td><td><abbr>ND</abbr></td><td><abbr>ND</abbr></td><td><abbr>ND</abbr></td></tr>
<tr class="sortbottom">
<td colspan="7" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Sources:</b> See template.</td></tr>
</tbody></table>

<center>
<table class="wikitable sortable mw-collapsible mw-collapsed">
<caption class="nowrap"> Endogenous estradiol production rates and plasma estrogen levels</caption>
<tbody><tr>
<th>Group</th><th><abbr>E2</abbr> (<abbr>prod</abbr>)</th><th><abbr>E2</abbr> (levels)</th><th><abbr>E1</abbr> (levels)</th><th><abbr>Ratio</abbr></th></tr>
<tr>
<td>Pubertal girls<sup>a</sup><br><span>&nbsp;</span><span>&nbsp;</span>Tanner stage I (childhood)<br><span>&nbsp;</span><span>&nbsp;</span>Tanner stage II (ages 8–12)<br><span>&nbsp;</span><span>&nbsp;</span>Tanner stage III (ages 10–13)<br><span>&nbsp;</span><span>&nbsp;</span>Tanner stage IV (ages 11–14)<br><span>&nbsp;</span><span>&nbsp;</span>Tanner stage V (ages 12–15)<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>Follicular (days 1–14)<br><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span><span>&nbsp;</span>Luteal (days 15–28)</td><td><span>&nbsp;</span><br>?<br>?<br>?<br>?<br><span>&nbsp;</span><br>?<br>?</td><td><span>&nbsp;</span><br>9 (&lt;9–20) pg/mL<br>15 (&lt;9–30) pg/mL<br>27 (&lt;9–60) pg/mL<br>55 (16–85) pg/mL<br><span>&nbsp;</span><br>50 (30–100) pg/mL<br>130 (70–300) pg/mL</td><td><span>&nbsp;</span><br>13 (&lt;9–23) pg/mL<br>18 (10–37) pg/mL<br>26 (17–58) pg/mL<br>36 (23–69) pg/mL<br><span>&nbsp;</span><br>44 (30–89) pg/mL<br>75 (39–160) pg/mL</td><td><span>&nbsp;</span><br>?<br>?<br>?<br>?<br><span>&nbsp;</span><br>?<br>?</td></tr>
<tr>
<td>Prepubertal boys</td><td>?</td><td>2–8 pg/mL</td><td>?</td><td>?</td></tr>
<tr>
<td>Premenopausal women<br><span>&nbsp;</span><span>&nbsp;</span>Early follicular phase (days 1–4)<br><span>&nbsp;</span><span>&nbsp;</span>Mid follicular phase (days 5–9)<br><span>&nbsp;</span><span>&nbsp;</span>Late follicular phase (days 10–14)<br><span>&nbsp;</span><span>&nbsp;</span>Luteal phase (days 15–28)<br><span>&nbsp;</span><span>&nbsp;</span>Oral contraceptive (anovulatory)</td><td><span>&nbsp;</span><br>30–100<span>&nbsp;</span>µg/day<br>100–160<span>&nbsp;</span>µg/day<br>320–640<span>&nbsp;</span>µg/day<br>300<span>&nbsp;</span>µg/day<br>?</td><td><span>&nbsp;</span><br>40–60 pg/mL<br>60–100 pg/mL<br>200–400 pg/mL<br>190 pg/mL<br>12–50 pg/mL</td><td><span>&nbsp;</span><br>40–60 pg/mL<br>?<br>170–200 pg/mL<br>100–150 pg/mL<br>?</td><td><span>&nbsp;</span><br>0.5–1<br>?<br>1–2<br>1.5<br>?</td></tr>
<tr>
<td>Postmenopausal women</td><td>18<span>&nbsp;</span>µg/day</td><td>5–20 pg/mL</td><td>30–70 pg/mL</td><td>0.3–0.8</td></tr>
<tr>
<td>Pregnant women<br><span>&nbsp;</span><span>&nbsp;</span>First trimester (weeks 1–12)<br><span>&nbsp;</span><span>&nbsp;</span>Second trimester (weeks 13–26)<br><span>&nbsp;</span><span>&nbsp;</span>Third trimester (weeks 27–40)</td><td><span>&nbsp;</span><br>?<br>?<br>?</td><td><span>&nbsp;</span><br>1,000–5,000 pg/mL<br>5,000–15,000 pg/mL<br>10,000–40,000 pg/mL</td><td><span>&nbsp;</span><br>?<br>?<br>?</td><td><span>&nbsp;</span><br>?<br>?<br>?</td></tr>
<tr>
<td>Men<sup>a</sup></td><td>20–60<span>&nbsp;</span>µg/day</td><td>27 (20–55) pg/mL</td><td>20–90 pg/mL</td><td>0.4–0.6</td></tr>
<tr class="sortbottom">
<td colspan="5" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Format is "mean value (range)" or just "range". <b>Sources:</b> See template.</td></tr>
</tbody></table>
</center>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Protein binding and metabolic clearance rates of estrogens</caption>
<tbody><tr>
<th>Compound</th><th data-sort-type="number"><abbr>RBA</abbr> to<br><abbr>SHBG</abbr> (%)</th><th data-sort-type="number">Bound to<br><abbr>SHBG</abbr> (%)</th><th data-sort-type="number">Bound to<br><a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a> (%)</th><th data-sort-type="number">Total<br>bound (%)</th><th data-sort-type="number"><abbr>MCR</abbr><br>(L/day/m<sup>2</sup>)</th></tr>
<tr>
<td>17β-Estradiol</td><td>50</td><td>37</td><td>61</td><td>98</td><td>580</td></tr>
<tr>
<td>Estrone</td><td>12</td><td>16</td><td>80</td><td>96</td><td>1050</td></tr>
<tr>
<td>Estriol</td><td>0.3</td><td>1</td><td>91</td><td>92</td><td>1110</td></tr>
<tr>
<td>Estrone sulfate</td><td>0</td><td>0</td><td>99</td><td>99</td><td>80</td></tr>
<tr>
<td>17β-Dihydroequilin</td><td>30</td><td>?</td><td>?</td><td>?</td><td>1250</td></tr>
<tr>
<td><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></td><td>8</td><td>26</td><td>13</td><td>?</td><td>2640</td></tr>
<tr>
<td>17β-Dihydroequilin sulfate</td><td>0</td><td>?</td><td>?</td><td>?</td><td>375</td></tr>
<tr>
<td>Equilin sulfate</td><td>0</td><td>?</td><td>?</td><td>?</td><td>175</td></tr>
<tr>
<td>Δ<sup>8</sup>-Estrone</td><td>?</td><td>?</td><td>?</td><td>?</td><td>1710</td></tr>
<tr class="sortbottom">
<td colspan="6" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> <abbr>RBA</abbr> for <abbr>SHBG</abbr> (%) is compared to 100% for testosterone. <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


<p>CEEs are naturally occurring estrane steroids.<span class="mw-ref" id="cite_ref-pmid16112947_1-26"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-8"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> They are in conjugate form, as the <a href="Sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium" title="Sodium">sodium</a> salts of the C17β sulfate esters.<span class="mw-ref" id="cite_ref-pmid16112947_1-27"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-9"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The estrogens in CEEs, in their unconjugated active forms, include bioidentical human estrogens like estradiol and estrone as well as equine-specific estrogens such as <a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">equilin</a> and 17β-dihydroequilin.<span class="mw-ref" id="cite_ref-pmid16112947_1-28"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-10"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The equine estrogens differ from human estrogens in that they have additional double bonds in the B ring of the steroid nucleus.<span class="mw-ref" id="cite_ref-pmid16112947_1-29"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-11"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> CEEs contain both 17β-estrogens like estradiol and 17β-dihydroequilin and the C17α epimers like 17α-estradiol and 17α-dihydroequilin.<span class="mw-ref" id="cite_ref-pmid16112947_1-30"><a href="#cite_note-pmid16112947-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FritzSperoff2012_6-12"><a href="#cite_note-FritzSperoff2012-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>
<span>
</span><table role="presentation" cellpadding="0" style="border-spacing:0; margin-left: auto; margin-right: auto; border: none;">
<tbody><tr>
<td><div class="thumb center" style="margin: 1em auto;">
<div class="thumbinner" style="width:802px; ">
<div style="clear: both; font-weight: bold; font-size: 106.4%; text-align: center; background-color: aliceblue;margin-bottom:3px;"> Chemical structures of equine estrogens<span class="mw-ref" id="cite_ref-pmid24176763_11-2"><a href="#cite_note-pmid24176763-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-pmid18599548_52-0"><a href="#cite_note-pmid18599548-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></div>
<div style="position:relative; width:800px; height:477px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:0px; top:0px; width:800px; position:absolute"> <figure-inline><span><img src="../I/m/Chemical_structures_of_equine_estrogens_no_labels.png" tppabs="https://ptable.com/wiki/compounds/I/m/Chemical_structures_of_equine_estrogens_no_labels.png" data-file-width="3435" data-file-height="2050" data-file-type="bitmap" height="477" width="800"></span></figure-inline>
</div> 
<div style="text-align:center; font-size:14px; line-height:110%;">
<div style="background-color:transparent; color:black"><div id="annotation_205x185" style="position:absolute; left:205px; top:185px;      line-height:110% "><span style="background-color:transparent; ">Estrone</span></div>
<div id="annotation_190x315" style="position:absolute; left:190px; top:315px;      line-height:110% "><span style="background-color:transparent; ">17β-Estradiol</span></div>
<div id="annotation_190x443" style="position:absolute; left:190px; top:443px;      line-height:110% "><span style="background-color:transparent; "><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">17α-Estradiol</a></span></div>

<div id="annotation_375x185" style="position:absolute; left:375px; top:185px;      line-height:110% "><span style="background-color:transparent; "><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></span></div>
<div id="annotation_332x315" style="position:absolute; left:332px; top:315px;      line-height:110% "><span style="background-color:transparent; ">17β-Dihydroequilin</span></div>
<div id="annotation_332x443" style="position:absolute; left:332px; top:443px;      line-height:110% "><span style="background-color:transparent; ">17α-Dihydroequilin</span></div>

<div id="annotation_533x185" style="position:absolute; left:533px; top:185px;      line-height:110% "><span style="background-color:transparent; "><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></span></div>
<div id="annotation_487x315" style="position:absolute; left:487px; top:315px;      line-height:110% "><span style="background-color:transparent; ">17β-Dihydroequilenin</span></div>
<div id="annotation_487x443" style="position:absolute; left:487px; top:443px;      line-height:110% "><span style="background-color:transparent; ">17α-Dihydroequilenin</span></div>

<div id="annotation_685x185" style="position:absolute; left:685px; top:185px;      line-height:110% "><span style="background-color:transparent; ">Δ<sup>8</sup>-Estrone</span></div>
<div id="annotation_666x315" style="position:absolute; left:666px; top:315px;      line-height:110% "><span style="background-color:transparent; ">Δ<sup>8</sup>-17β-Estradiol</span></div></div>
</div>
</div>
<div class="thumbcaption" style="clear:left"><div style="float:left;margin-right:0.5em"><figure-inline><span><img src="../I/m/Interactive_icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Interactive_icon.svg.png" data-file-width="133" data-file-height="200" data-file-type="drawing" height="27" width="18"></span></figure-inline></div>This diagram illustrates the chemical structures of the active/unconjugated forms of the equine estrogens present in conjugated estrogens.</div>
</div>
</div></td></tr>
</tbody></table>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Conjugated estriol, an extract of the urine of pregnant women and sold under the brand names Progynon and Emmenin in the 1930s, was the predecessor of Premarin.<span class="mw-ref" id="cite_ref-FeldbergLadd-Taylor2003_53-0"><a href="#cite_note-FeldbergLadd-Taylor2003-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Both of these products contained conjugated estrogens similarly to Premarin, but the estrogens were human estrogens as opposed to equine estrogens and the composition differed. The major active ingredient in Progynon and Emmenin was estriol glucuronide.</p>

<p>Estrone sulfate was first isolated from the urine of pregnant mares in the late 1930s by researchers in the Department of Biochemistry at University of Toronto.<span class="mw-ref" id="cite_ref-SchachterMarrian1938_54-0"><a href="#cite_note-SchachterMarrian1938-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> Premarin was first introduced in 1941 by Wyeth Ayerst as a treatment for hot flushes and other symptoms of menopause; at that time, Wyeth Ayerst only had to prove its safety, and not its efficacy.<span class="mw-ref" id="cite_ref-MDD_55-0"><a href="#cite_note-MDD-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span>  In response to the 1962 Kefauver Harris Amendment the FDA had its efficacy reviewed, and in 1972 found it effective for menopausal symptoms and probably effective for osteoporosis.<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> The review also determined  that two estrogens – estrone sulfate and equilin sulfate – were primarily responsible for the activity of Premarin, and it laid the groundwork for Abbreviated New Drug Application (ANDA) submissions of generic versions.<span class="mw-ref" id="cite_ref-MDD_55-1"><a href="#cite_note-MDD-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> In 1984 an NIH consensus panel found that estrogens were effective for preventing osteoporosis<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> and 1986 the FDA announced in the Federal Register that Premarin was effective for preventing osteoporosis.<span class="mw-ref" id="cite_ref-Woodcock1997_58-0"><a href="#cite_note-Woodcock1997-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> This announcement led to a rapid growth in sales, and interest from generic manufacturers to introduce generic versions.<span class="mw-ref" id="cite_ref-MDD_55-2"><a href="#cite_note-MDD-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>

<p>Conjugated estrogens was introduced for medical use under the brand name Premarin in Canada in 1941, in the United States in 1942, and in the United Kingdom in 1956.<span class="mw-ref" id="cite_ref-PanayBriggs2015_59-0"><a href="#cite_note-PanayBriggs2015-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<p><i>Estrogens, conjugated</i> is the generic name of the drug and its <abbr>USP</abbr> and <abbr>JAN</abbr>.<span class="mw-ref" id="cite_ref-ChemIDplus_60-0"><a href="#cite_note-ChemIDplus-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> It is also known as <i>conjugated estrogens</i> or as <i>conjugated equine estrogens</i>.<span class="mw-ref" id="cite_ref-DrugBank_4-3"><a href="#cite_note-DrugBank-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The brand name Premarin is a contraction of "<b>pre</b>gnant <b>mar</b>es' ur<b>in</b>e".</p>

<p>CEEs are marketed under a large number of brand names throughout the world.<span class="mw-ref" id="cite_ref-Martindale_5-10"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The major brand name of the natural form of CEEs manufactured from the urine of pregnant mares is Premarin.<span class="mw-ref" id="cite_ref-Martindale_5-11"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Major brand names of fully synthetic versions of CEEs include Cenestin and Enjuvia in the United States and C.E.S. and Congest in Canada.<span class="mw-ref" id="cite_ref-Martindale_5-12"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-MoscouSnipe2012_7-1"><a href="#cite_note-MoscouSnipe2012-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-HumansOrganization2007_8-1"><a href="#cite_note-HumansOrganization2007-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> CEEs are also formulated in combination with progestins.<span class="mw-ref" id="cite_ref-Martindale_5-13"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Major brand names of CEEs in combination with <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a> include Prempro and Premphase in the United States, Premplus in Canada, Premique in the United Kingdom and Ireland, Premia in Australia and New Zealand, and Premelle in South Africa.<span class="mw-ref" id="cite_ref-Martindale_5-14"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-HochadelAvorn2007_61-0"><a href="#cite_note-HochadelAvorn2007-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> Prempak-C is a combination of CEEs and <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">norgestrel</a> which is used in the United Kingdom and Ireland, and Prempak N is a combination of CEEs and medrogestone which is used in South Africa.<span class="mw-ref" id="cite_ref-Martindale_5-15"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Many of the aforementioned brand names are also used in other, non-English-speaking countries.<span class="mw-ref" id="cite_ref-Martindale_5-16"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    


<p>CEEs are marketed and available widely throughout the world.<span class="mw-ref" id="cite_ref-Martindale_5-17"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com-Premarin_25-1"><a href="#cite_note-Drugs.com-Premarin-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> This includes in all English-speaking countries, throughout Europe, Latin America, Asia, and elsewhere in the world.<span class="mw-ref" id="cite_ref-Martindale_5-18"><a href="#cite_note-Martindale-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com-Premarin_25-2"><a href="#cite_note-Drugs.com-Premarin-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Usage">Usage</h3></summary>
    
<p>Besides ethinylestradiol used in birth control pills, CEEs were the second most used estrogen in the U.S. in 2016, with 4.2<span>&nbsp;</span>million total prescriptions filled.<span class="mw-ref" id="cite_ref-DrugStats2017_16-1"><a href="#cite_note-DrugStats2017-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The first most used estrogen was estradiol, with 13.4<span>&nbsp;</span>million total prescriptions filled.<span class="mw-ref" id="cite_ref-DrugStats2017_16-2"><a href="#cite_note-DrugStats2017-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> CEEs were the 206th most prescribed medication in the U.S. that year.<span class="mw-ref" id="cite_ref-DrugStats2017_16-3"><a href="#cite_note-DrugStats2017-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Health_effects">Health effects</h3></summary>
    
<p>Research starting in 1975 showed substantially increased risk of endometrial cancer.<span class="mw-ref" id="cite_ref-62"><a href="#cite_note-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Since 1976 the drug has carried a label warning about the risk.<span class="mw-ref" id="cite_ref-Singer_64-0"><a href="#cite_note-Singer-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> As part of the Women's Health Initiative sponsored by the National Institutes of Health, a large-scale clinical trial of menopausal HRT showed that long-term use of estrogen and a progestin may increase the risk of strokes, heart attacks, blood clots, and breast cancer.<span class="mw-ref" id="cite_ref-Brunner_65-0"><a href="#cite_note-Brunner-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> Following these results, Wyeth experienced a significant decline in its sales of Premarin, Prempro (CEEs and <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>), and related products, from over $2 billion in 2002 to just over $1 billion in 2006.<span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Litigation">Litigation</h3></summary>
    
<p>This drug has been the subject of litigation; more than 13,000 people have sued Wyeth between 2002 and 2009. Wyeth and Pharmacia &amp; Upjohn prevailed in the vast majority of hormone therapy cases previously set for trial through a combination of rulings by judges, verdicts by juries, and dismissals by plaintiffs themselves.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Of the company's losses, two of the jury verdicts were reversed post-trial and others are being challenged on appeal. Wyeth also won five summary judgments on Prempro cases and had 15 cases voluntarily dismissed by plaintiffs. The company won dismissals in another 3,000 cases.<span class="mw-ref" id="cite_ref-Bloomberg_2010_68-0"><a href="#cite_note-Bloomberg_2010-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> In 2006, Mary Daniel, in a trial in Philadelphia, was awarded $1.5 million in compensatory damages as well as undisclosed punitive damages. As of 2010, Wyeth had won the last four of five cases, most recently in Virginia, finding that they were not responsible for the breast cancer of plaintiff Georgia Torkie-Tork.<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Wyeth has been quoted as saying "many risk factors associated with breast cancer have been identified, but science cannot establish what role any particular risk factor or combination play in any individual woman's breast cancer." <span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> Wyeth's counsel in the case also noted that in the WHI trial, 99.62% of women took the drug and "did not get breast cancer."<span class="mw-ref" id="cite_ref-Bloomberg_2010_68-1"><a href="#cite_note-Bloomberg_2010-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Animal_welfare">Animal welfare</h3></summary>
    
<p>Animal welfare groups claim that animal husbandry and urine collection methods used in the production of CEEs cause undue stress and suffering to the mares involved. Animal activists have made claims of abuses ranging from inadequate stall size, long periods of confinement, cumbersome urine collection, and continuous breeding cycles. After reaching advanced age, many of the mares are adopted for recreation use, while some are sent to feed lots for slaughter. Despite the controversy, the USDA called the CEEs HRT industry a model of self-regulation.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Conjugated estrogens/medroxyprogesterone acetate</li>
<li>Conjugated estrogens/norgestrel</li>
<li>Conjugated estrogens/methyltestosterone</li>
<li>Bazedoxifene/conjugated estrogens</li>
<li>Estrogenic substances</li>
<li>Conjugated estriol</li>
<li>List of combined sex-hormonal preparations</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Notes">Notes</h2></summary>
    
<div class="reflist " style=" list-style-type: lower-alpha;">
<div class="mw-references-wrap"><ol class="mw-references references" data-mw-group="lower-alpha"></ol></div></div>
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap"><ol class="mw-references references" data-mw-group="note"></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-pmid16112947-1"> <span id="mw-reference-text-cite_note-pmid16112947-1" class="mw-reference-text"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl H (2005). <a href="javascript:if(confirm('http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf'" tppabs="http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf" class="external text external">"Pharmacology of estrogens and progestogens: influence of different routes of administration"</a> <span class="cs1-format">(PDF)</span>. <i>Climacteric</i>. 8 Suppl 1: 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>.</cite></span></li><li id="cite_note-Drugs@FDA-2"> <span id="mw-reference-text-cite_note-Drugs@FDA-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/cder/daf/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/cder/daf/'" tppabs="http://www.accessdata.fda.gov/scripts/cder/daf/" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>. United States Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">19 February</span> 2018</span>.</cite></span></li><li id="cite_note-PremarinLabel-3"> <span id="mw-reference-text-cite_note-PremarinLabel-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://labeling.pfizer.com/showlabeling.aspx?id=131  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://labeling.pfizer.com/showlabeling.aspx?id=131'" tppabs="http://labeling.pfizer.com/showlabeling.aspx?id=131" class="external text external">"PREMARIN- estrogens, conjugated tablet, film coated Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc"</a>. <i>labeling.pfizer.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 June</span> 2019</span>.</cite></span></li><li id="cite_note-DrugBank-4"> <span id="mw-reference-text-cite_note-DrugBank-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00286'" tppabs="https://www.drugbank.ca/drugs/DB00286" class="external text external">"Conjugated estrogens"</a>.</cite></span></li><li id="cite_note-Martindale-5"> <span id="mw-reference-text-cite_note-Martindale-5" class="mw-reference-text"><cite id="CITEREFSweetman,_Sean_C.2009" class="citation book cs1">Sweetman, Sean C., ed. (2009). <a href="javascript:if(confirm('https://www.medicinescomplete.com/mc/rem/current/mono-E61.htm?q=C&t=advanced&ss=mn&p=57  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicinescomplete.com/mc/rem/current/mono-E61.htm?q=C&t=advanced&ss=mn&p=57'" tppabs="https://www.medicinescomplete.com/mc/rem/current/mono-E61.htm?q=C&t=advanced&ss=mn&p=57" class="external text external">"Sex hormones and their modulators"</a>. <i>Martindale: The Complete Drug Reference</i> (36th ed.). London: Pharmaceutical Press. p.<span>&nbsp;</span>2087. ISBN<span>&nbsp;</span><bdi>978-0-85369-840-1</bdi>.</cite></span></li><li id="cite_note-FritzSperoff2012-6"> <span id="mw-reference-text-cite_note-FritzSperoff2012-6" class="mw-reference-text"><cite id="CITEREFMarc_A._FritzLeon_Speroff2012" class="citation book cs1">Marc A. Fritz; Leon Speroff (28 March 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=KZLubBxJEwEC&pg=PA751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=KZLubBxJEwEC&pg=PA751'" tppabs="https://books.google.com/books?id=KZLubBxJEwEC&pg=PA751" class="external text external"><i>Clinical Gynecologic Endocrinology and Infertility</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>751–3. ISBN<span>&nbsp;</span><bdi>978-1-4511-4847-3</bdi>.</cite></span></li><li id="cite_note-MoscouSnipe2012-7"> <span id="mw-reference-text-cite_note-MoscouSnipe2012-7" class="mw-reference-text"><cite id="CITEREFKathy_MoscouKaren_Snipe2012" class="citation book cs1">Kathy Moscou; Karen Snipe (1 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=1nvESqVnxc0C&pg=PA573  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=1nvESqVnxc0C&pg=PA573'" tppabs="https://books.google.com/books?id=1nvESqVnxc0C&pg=PA573" class="external text external"><i>Pharmacology for Pharmacy Technicians Pageburst E-Book on VitalSource2: Pharmacology for Pharmacy Technicians Pageburst E-Book on VitalSource</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>573–. ISBN<span>&nbsp;</span><bdi>978-0-323-08578-6</bdi>.</cite></span></li><li id="cite_note-HumansOrganization2007-8"> <span id="mw-reference-text-cite_note-HumansOrganization2007-8" class="mw-reference-text"><cite id="CITEREFIARC_Working_Group_on_the_Evaluation_of_Carcinogenic_Risks_to_HumansWorld_Health_OrganizationInternational_Agency_for_Research_on_Cancer2007" class="citation book cs1">IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). <a href="javascript:if(confirm('https://books.google.com/books?id=aGDU5xibtNgC&pg=PA378  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aGDU5xibtNgC&pg=PA378'" tppabs="https://books.google.com/books?id=aGDU5xibtNgC&pg=PA378" class="external text external"><i>Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy</i></a>. World Health Organization. pp.<span>&nbsp;</span>378–. ISBN<span>&nbsp;</span><bdi>978-92-832-1291-1</bdi>.</cite></span></li><li id="cite_note-pmid28664754-9"> <span id="mw-reference-text-cite_note-pmid28664754-9" class="mw-reference-text"><cite id="CITEREFPickarArcherKaganPinkerton2017" class="citation journal cs1">Pickar JH, Archer DF, Kagan R, Pinkerton JV, Taylor HS (August 2017). "Safety and benefit considerations for menopausal hormone therapy". <i>Expert Opin Drug Saf</i>. <b>16</b> (8): 941–954. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F14740338.2017.1343298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F14740338.2017.1343298'" tppabs="https://doi.org/10.1080%2F14740338.2017.1343298" class="external text external">10.1080/14740338.2017.1343298</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28664754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28664754'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28664754" class="external text external">28664754</a>.</cite></span></li><li id="cite_note-pmid25223916-10"> <span id="mw-reference-text-cite_note-pmid25223916-10" class="mw-reference-text"><cite id="CITEREFScarabin2014" class="citation journal cs1">Scarabin PY (December 2014). "Hormones and venous thromboembolism among postmenopausal women". <i>Climacteric</i>. 17 Suppl 2: 34–7. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697137.2014.956717  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697137.2014.956717'" tppabs="https://doi.org/10.3109%2F13697137.2014.956717" class="external text external">10.3109/13697137.2014.956717</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25223916  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25223916'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25223916" class="external text external">25223916</a>.</cite></span></li><li id="cite_note-pmid24176763-11"> <span id="mw-reference-text-cite_note-pmid24176763-11" class="mw-reference-text"><cite id="CITEREFBhavnaniStanczyk2014" class="citation journal cs1">Bhavnani BR, Stanczyk FZ (July 2014). "Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action". <i>J. Steroid Biochem. Mol. Biol</i>. <b>142</b>: 16–29. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jsbmb.2013.10.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jsbmb.2013.10.011'" tppabs="https://doi.org/10.1016%2Fj.jsbmb.2013.10.011" class="external text external">10.1016/j.jsbmb.2013.10.011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24176763  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24176763'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24176763" class="external text external">24176763</a>.</cite></span></li><li id="cite_note-Quereda2017-12"> <span id="mw-reference-text-cite_note-Quereda2017-12" class="mw-reference-text"><cite id="CITEREFQuereda2017" class="citation book cs1">Quereda, Francisco (2017). "Hormone Therapy (I): Estrogens, Progestogens, and Androgens". <i>Menopause</i>. pp.<span>&nbsp;</span>181–196. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-319-59318-0_11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-319-59318-0_11'" tppabs="https://doi.org/10.1007%2F978-3-319-59318-0_11" class="external text external">10.1007/978-3-319-59318-0_11</a>. ISBN<span>&nbsp;</span><bdi>978-3-319-59317-3</bdi>.</cite></span></li><li id="cite_note-pmid28301216-13"> <span id="mw-reference-text-cite_note-pmid28301216-13" class="mw-reference-text"><cite id="CITEREFL'Hermite2017" class="citation journal cs1">L'Hermite M (August 2017). "Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal". <i>Climacteric</i>. <b>20</b> (4): 331–338. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697137.2017.1291607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697137.2017.1291607'" tppabs="https://doi.org/10.1080%2F13697137.2017.1291607" class="external text external">10.1080/13697137.2017.1291607</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28301216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28301216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28301216" class="external text external">28301216</a>.</cite></span></li><li id="cite_note-pmid24398406-14"> <span id="mw-reference-text-cite_note-pmid24398406-14" class="mw-reference-text"><cite id="CITEREFSimon2014" class="citation journal cs1">Simon JA (July 2014). "What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?". <i>Menopause</i>. <b>21</b> (7): 769–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FGME.0000000000000169  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FGME.0000000000000169'" tppabs="https://doi.org/10.1097%2FGME.0000000000000169" class="external text external">10.1097/GME.0000000000000169</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24398406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24398406'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24398406" class="external text external">24398406</a>.</cite></span></li><li id="cite_note-pmid19179815-15"> <span id="mw-reference-text-cite_note-pmid19179815-15" class="mw-reference-text"><cite id="CITEREFHoltorf2009" class="citation journal cs1">Holtorf K (January 2009). "The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?". <i>Postgrad Med</i>. <b>121</b> (1): 73–85. doi:<a href="javascript:if(confirm('https://doi.org/10.3810%2Fpgm.2009.01.1949  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3810%2Fpgm.2009.01.1949'" tppabs="https://doi.org/10.3810%2Fpgm.2009.01.1949" class="external text external">10.3810/pgm.2009.01.1949</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19179815  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19179815'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19179815" class="external text external">19179815</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:2060730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:2060730'" tppabs="https://api.semanticscholar.org/CorpusID:2060730" class="external text external">2060730</a>.</cite></span></li><li id="cite_note-DrugStats2017-16"> <span id="mw-reference-text-cite_note-DrugStats2017-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/EstrogensConjugated  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/EstrogensConjugated'" tppabs="https://clincalc.com/DrugStats/Drugs/EstrogensConjugated" class="external text external">"Estrogens, Conjugated - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFGreerGinsbergForbes2006" class="citation book cs1">Greer, Iain A.; Ginsberg, Jeff; Forbes, Charles (29 December 2006). <a href="javascript:if(confirm('https://books.google.com/books?id=GsPie79hwsIC&pg=PA222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=GsPie79hwsIC&pg=PA222'" tppabs="https://books.google.com/books?id=GsPie79hwsIC&pg=PA222" class="external text external"><i>Women's vascular health</i></a>. CRC Press. ISBN<span>&nbsp;</span><bdi>9780340809976</bdi>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFNezhatNezhatNezhat2008" class="citation book cs1">Nezhat, Camran; Nezhat, Farr; Nezhat, Ceana (7 July 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=Z0gYy2hdn3QC&pg=PA266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Z0gYy2hdn3QC&pg=PA266'" tppabs="https://books.google.com/books?id=Z0gYy2hdn3QC&pg=PA266" class="external text external"><i>Nezhat's Operative gynecologic laparoscopy and hysteroscopy</i></a>. Cambridge University Press. ISBN<span>&nbsp;</span><bdi>9781139472005</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2015</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFMaedaLazaretti-CastroMaedaLazaretti-Castro2014" class="citation journal cs1">Maeda, Sergio Setsuo; Lazaretti-Castro, Marise; Maeda, Sergio Setsuo; Lazaretti-Castro, Marise (2014). <a href="javascript:if(confirm('http://vml029.epm.br/bitstream/11600/8274/1/S0004-27302014000200162.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://vml029.epm.br/bitstream/11600/8274/1/S0004-27302014000200162.pdf'" tppabs="http://vml029.epm.br/bitstream/11600/8274/1/S0004-27302014000200162.pdf" class="external text external">"An overview on the treatment of postmenopausal osteoporosis"</a> <span class="cs1-format">(PDF)</span>. <i>Arquivos Brasileiros de Endocrinologia &amp; Metabologia</i>. <b>58</b> (2): 162–171. doi:<a href="javascript:if(confirm('https://doi.org/10.1590%2F0004-2730000003039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2F0004-2730000003039'" tppabs="https://doi.org/10.1590%2F0004-2730000003039" class="external text external">10.1590/0004-2730000003039</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0004-2730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0004-2730'" tppabs="https://www.worldcat.org/issn/0004-2730" class="external text external">0004-2730</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24830593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24830593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24830593" class="external text external">24830593</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFMajeedAslamJavedKhaliq2014" class="citation journal cs1">Majeed, W.; Aslam, B.; Javed, I.; Khaliq, T.; Muhammad, F.; Ali, A.; Raza, A. (2014). <a href="javascript:if(confirm('https://doi.org/10.7314/apjcp.2014.15.8.3353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7314/apjcp.2014.15.8.3353'" tppabs="https://doi.org/10.7314/apjcp.2014.15.8.3353" class="external text external">"Breast cancer: major risk factors and recent developments in treatment"</a>. <i>Asian Pac J Cancer Prev</i>. <b>15</b> (8): 3353–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.7314%2Fapjcp.2014.15.8.3353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7314%2Fapjcp.2014.15.8.3353'" tppabs="https://doi.org/10.7314%2Fapjcp.2014.15.8.3353" class="external text external">10.7314/apjcp.2014.15.8.3353</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24870721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24870721'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24870721" class="external text external">24870721</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFLearning2015" class="citation book cs1">Learning, Jones &amp; Bartlett (14 January 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=o_vPBgAAQBAJ&pg=PA448&dq=premarin+prostate+cancer  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=o_vPBgAAQBAJ&pg=PA448&dq=premarin+prostate+cancer#v=onepage'" tppabs="https://books.google.com/books?id=o_vPBgAAQBAJ&pg=PA448&dq=premarin+prostate+cancer#v=onepage" class="external text external"><i>2015 Nurse's Drug Handbook</i></a>. Jones &amp; Bartlett Publishers. ISBN<span>&nbsp;</span><bdi>9781284091373</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2015</span>.</cite></span></li><li id="cite_note-OettelSchillinger2012-23"> <span id="mw-reference-text-cite_note-OettelSchillinger2012-23" class="mw-reference-text"><cite id="CITEREFMichael_OettelEkkehard_Schillinger2012" class="citation book cs1">Michael Oettel; Ekkehard Schillinger (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=wBvyCAAAQBAJ&pg=PA540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=wBvyCAAAQBAJ&pg=PA540'" tppabs="https://books.google.com/books?id=wBvyCAAAQBAJ&pg=PA540" class="external text external"><i>Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>540–. ISBN<span>&nbsp;</span><bdi>978-3-642-60107-1</bdi>.</cite></span></li><li id="cite_note-DenisGriffiths1999-24"> <span id="mw-reference-text-cite_note-DenisGriffiths1999-24" class="mw-reference-text"><cite id="CITEREFLouis_J_DenisKeith_GriffithsAmir_V_KaisaryGerald_P_Murphy1999" class="citation book cs1">Louis J Denis; Keith Griffiths; Amir V Kaisary; Gerald P Murphy (1 March 1999). <a href="javascript:if(confirm('https://books.google.com/books?id=GreZlojD-tYC&pg=PA297  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=GreZlojD-tYC&pg=PA297'" tppabs="https://books.google.com/books?id=GreZlojD-tYC&pg=PA297" class="external text external"><i>Textbook of Prostate Cancer: Pathology, Diagnosis and Treatment: Pathology, Diagnosis and Treatment</i></a>. CRC Press. pp.<span>&nbsp;</span>297–. ISBN<span>&nbsp;</span><bdi>978-1-85317-422-3</bdi>.</cite></span></li><li id="cite_note-Drugs.com-Premarin-25"> <span id="mw-reference-text-cite_note-Drugs.com-Premarin-25" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/premarin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/premarin.html'" tppabs="https://www.drugs.com/international/premarin.html" class="external text external">"Premarin"</a>.</cite></span></li><li id="cite_note-HorskyPresl1981-26"> <span id="mw-reference-text-cite_note-HorskyPresl1981-26" class="mw-reference-text"><cite id="CITEREFHorskýPresl1981" class="citation book cs1">Horský, Jan; Presl, Jiří (1981). <a href="javascript:if(confirm('https://books.google.com/books?id=7IrpCAAAQBAJ&pg=PA310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7IrpCAAAQBAJ&pg=PA310'" tppabs="https://books.google.com/books?id=7IrpCAAAQBAJ&pg=PA310" class="external text external">"Hormonal Treatment of Disorders of the Menstrual Cycle"</a>.  In J. Horsky; J. Presl (eds.). <i>Ovarian Function and its Disorders: Diagnosis and Therapy</i>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>309–332. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-94-009-8195-9_11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-94-009-8195-9_11'" tppabs="https://doi.org/10.1007%2F978-94-009-8195-9_11" class="external text external">10.1007/978-94-009-8195-9_11</a>. ISBN<span>&nbsp;</span><bdi>978-94-009-8195-9</bdi>.</cite></span></li><li id="cite_note-Piersol1975-27"> <span id="mw-reference-text-cite_note-Piersol1975-27" class="mw-reference-text"><cite id="CITEREFGeorge_Morris_Piersol1975" class="citation book cs1">George Morris Piersol (1975). <a href="javascript:if(confirm('https://books.google.com/books?id=RiE9K5bgKcsC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=RiE9K5bgKcsC'" tppabs="https://books.google.com/books?id=RiE9K5bgKcsC" class="external text external"><i>The Cyclopedia of Medicine, Surgery, Specialties</i></a>. F. A. Davis Company.</cite></span></li><li id="cite_note-MorleyBerg1999-28"> <span id="mw-reference-text-cite_note-MorleyBerg1999-28" class="mw-reference-text"><cite id="CITEREFJohn_E._MorleyLucretia_van_den_Berg1999" class="citation book cs1">John E. Morley; Lucretia van den Berg (5 November 1999). <a href="javascript:if(confirm('https://books.google.com/books?id=hGD0BwAAQBAJ&pg=PA172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=hGD0BwAAQBAJ&pg=PA172'" tppabs="https://books.google.com/books?id=hGD0BwAAQBAJ&pg=PA172" class="external text external"><i>Endocrinology of Aging</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>172–. ISBN<span>&nbsp;</span><bdi>978-1-59259-715-4</bdi>.</cite></span></li><li id="cite_note-Shorr2007-29"> <span id="mw-reference-text-cite_note-Shorr2007-29" class="mw-reference-text"><cite id="CITEREFRonald_I._Shorr2007" class="citation book cs1">Ronald I. Shorr (11 April 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=-gmjBQAAQBAJ&pg=PA462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=-gmjBQAAQBAJ&pg=PA462'" tppabs="https://books.google.com/books?id=-gmjBQAAQBAJ&pg=PA462" class="external text external"><i>Drugs for the Geriatric Patient E-Book: Text with BONUS Handheld Software</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>462–. ISBN<span>&nbsp;</span><bdi>978-1-4377-1035-9</bdi>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20161026041953/https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161026041953/https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm'" tppabs="https://web.archive.org/web/20161026041953/https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121062.htm" class="external text external">the original</a> on 26 October 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2018</span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-pmid26327865-31"> <span id="mw-reference-text-cite_note-pmid26327865-31" class="mw-reference-text"><cite id="CITEREFBińkowska2014" class="citation journal cs1">Bińkowska M (October 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375" class="external text external">"Menopausal hormone therapy and venous thromboembolism"</a>. <i>Prz Menopauzalny</i>. <b>13</b> (5): 267–72. doi:<a href="javascript:if(confirm('https://doi.org/10.5114%2Fpm.2014.46468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5114%2Fpm.2014.46468'" tppabs="https://doi.org/10.5114%2Fpm.2014.46468" class="external text external">10.5114/pm.2014.46468</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520375" class="external text external">4520375</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26327865  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26327865'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26327865" class="external text external">26327865</a>.</cite></span></li><li id="cite_note-pmid24081194-32"> <span id="mw-reference-text-cite_note-pmid24081194-32" class="mw-reference-text"><cite id="CITEREFSmithBlondonWigginsHarrington2014" class="citation journal cs1">Smith NL, Blondon M, Wiggins KL, Harrington LB, van Hylckama Vlieg A, Floyd JS, Hwang M, Bis JC, McKnight B, Rice KM, Lumley T, Rosendaal FR, Heckbert SR, Psaty BM (January 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198" class="external text external">"Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens"</a>. <i>JAMA Intern Med</i>. <b>174</b> (1): 25–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamainternmed.2013.11074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamainternmed.2013.11074'" tppabs="https://doi.org/10.1001%2Fjamainternmed.2013.11074" class="external text external">10.1001/jamainternmed.2013.11074</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636198" class="external text external">4636198</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24081194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24081194'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24081194" class="external text external">24081194</a>.</cite></span></li><li id="cite_note-pmid15467060-33"> <span id="mw-reference-text-cite_note-pmid15467060-33" class="mw-reference-text"><cite id="CITEREFSmithHeckbertLemaitreReiner2004" class="citation journal cs1">Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Weiss NS, Larson EB, Rosendaal FR, Psaty BM (October 2004). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.292.13.1581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.292.13.1581'" tppabs="https://doi.org/10.1001/jama.292.13.1581" class="external text external">"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis"</a>. <i>JAMA</i>. <b>292</b> (13): 1581–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.292.13.1581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.292.13.1581'" tppabs="https://doi.org/10.1001%2Fjama.292.13.1581" class="external text external">10.1001/jama.292.13.1581</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15467060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15467060'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15467060" class="external text external">15467060</a>.</cite></span></li><li id="cite_note-pmid27998619-34"> <span id="mw-reference-text-cite_note-pmid27998619-34" class="mw-reference-text"><cite id="CITEREFLekovicMiljicDmitrovicThachil2017" class="citation journal cs1">Lekovic D, Miljic P, Dmitrovic A, Thachil J (May 2017). "How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?". <i>Blood Rev</i>. <b>31</b> (3): 151–157. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.blre.2016.12.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.blre.2016.12.001'" tppabs="https://doi.org/10.1016%2Fj.blre.2016.12.001" class="external text external">10.1016/j.blre.2016.12.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27998619  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27998619'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27998619" class="external text external">27998619</a>.</cite></span></li><li id="cite_note-pmid23136837-35"> <span id="mw-reference-text-cite_note-pmid23136837-35" class="mw-reference-text"><cite id="CITEREFRoachLijferingHelmerhorstCannegieter2013" class="citation journal cs1">Roach RE, Lijfering WM, Helmerhorst FM, Cannegieter SC, Rosendaal FR, van Hylckama Vlieg A (January 2013). "The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy". <i>J. Thromb. Haemost</i>. <b>11</b> (1): 124–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fjth.12060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fjth.12060'" tppabs="https://doi.org/10.1111%2Fjth.12060" class="external text external">10.1111/jth.12060</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23136837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23136837'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23136837" class="external text external">23136837</a>.</cite></span></li><li id="cite_note-Buchsbaum2012-36"> <span id="mw-reference-text-cite_note-Buchsbaum2012-36" class="mw-reference-text"><cite id="CITEREFH.J._Buchsbaum2012" class="citation book cs1">H.J. Buchsbaum (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=z0LuBwAAQBAJ&pg=PA64  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=z0LuBwAAQBAJ&pg=PA64'" tppabs="https://books.google.com/books?id=z0LuBwAAQBAJ&pg=PA64" class="external text external"><i>The Menopause</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>64–. ISBN<span>&nbsp;</span><bdi>978-1-4612-5525-3</bdi>.</cite></span></li><li id="cite_note-FalconeHurd2013-37"> <span id="mw-reference-text-cite_note-FalconeHurd2013-37" class="mw-reference-text"><cite id="CITEREFTommaso_FalconeWilliam_W._Hurd2013" class="citation book cs1">Tommaso Falcone; William W. Hurd (22 May 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=TAYnR1b8jRkC&pg=PA5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=TAYnR1b8jRkC&pg=PA5'" tppabs="https://books.google.com/books?id=TAYnR1b8jRkC&pg=PA5" class="external text external"><i>Clinical Reproductive Medicine and Surgery: A Practical Guide</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>5–6. ISBN<span>&nbsp;</span><bdi>978-1-4614-6837-0</bdi>.</cite></span></li><li id="cite_note-Sanfilippo1998-38"> <span id="mw-reference-text-cite_note-Sanfilippo1998-38" class="mw-reference-text"><cite id="CITEREFJoseph_S._Sanfilippo1998" class="citation book cs1">Joseph S. Sanfilippo (January 1998). <a href="javascript:if(confirm('https://books.google.com/books?id=jfmB3aNSGfoC&pg=PA227  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jfmB3aNSGfoC&pg=PA227'" tppabs="https://books.google.com/books?id=jfmB3aNSGfoC&pg=PA227" class="external text external"><i>Primary Care in Obstetrics and Gynecology: A Handbook for Clinicians</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>220, 227. ISBN<span>&nbsp;</span><bdi>978-0-387-94739-6</bdi>. <q>Conjugated estrogens are absorbed with peak levels at 4 hours and a half-life of approximately 12 hours.</q></cite></span></li><li id="cite_note-pmid17443713-39"> <span id="mw-reference-text-cite_note-pmid17443713-39" class="mw-reference-text"><cite id="CITEREFCline2007" class="citation journal cs1">Cline JM (2007). "Assessing the mammary gland of nonhuman primates: effects of endogenous hormones and exogenous hormonal agents and growth factors". <i>Birth Defects Res. B Dev. Reprod. Toxicol</i>. <b>80</b> (2): 126–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fbdrb.20112  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fbdrb.20112'" tppabs="https://doi.org/10.1002%2Fbdrb.20112" class="external text external">10.1002/bdrb.20112</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17443713  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17443713'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17443713" class="external text external">17443713</a>.</cite></span></li><li id="cite_note-pmid16915215-40"> <span id="mw-reference-text-cite_note-pmid16915215-40" class="mw-reference-text"><cite id="CITEREFNotelovitz2006" class="citation journal cs1">Notelovitz M (March 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006" class="external text external">"Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause"</a>. <i>MedGenMed</i>. <b>8</b> (1): 85. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682006" class="external text external">1682006</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16915215  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16915215'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16915215" class="external text external">16915215</a>.</cite></span></li><li id="cite_note-pmid10914617-41"> <span id="mw-reference-text-cite_note-pmid10914617-41" class="mw-reference-text"><cite id="CITEREFNachtigallRajuBanerjeeWan2000" class="citation journal cs1">Nachtigall LE, Raju U, Banerjee S, Wan L, Levitz M (2000). "Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels". <i>Menopause</i>. <b>7</b> (4): 243–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00042192-200007040-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00042192-200007040-00006'" tppabs="https://doi.org/10.1097%2F00042192-200007040-00006" class="external text external">10.1097/00042192-200007040-00006</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1072-3714  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1072-3714'" tppabs="https://www.worldcat.org/issn/1072-3714" class="external text external">1072-3714</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10914617  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10914617'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10914617" class="external text external">10914617</a>.</cite></span></li><li id="cite_note-pmid4359746-42"> <span id="mw-reference-text-cite_note-pmid4359746-42" class="mw-reference-text"><cite id="CITEREFShearerHendrySommervilleFergusson1973" class="citation journal cs1">Shearer RJ, Hendry WF, Sommerville IF, Fergusson JD (December 1973). "Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer". <i>Br J Urol</i>. <b>45</b> (6): 668–77. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x" class="external text external">10.1111/j.1464-410x.1973.tb12238.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4359746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4359746'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4359746" class="external text external">4359746</a>.</cite></span></li><li id="cite_note-Greenblatt1966-43"> <span id="mw-reference-text-cite_note-Greenblatt1966-43" class="mw-reference-text"><cite id="CITEREFJorge_Martinez-ManautouHarry_W._Rudel1966" class="citation book cs1">Jorge Martinez-Manautou; Harry W. Rudel (1966). "Antiovulatory Activity of Several Synthetic and Natural Estrogens".  In Robert Benjamin Greenblatt (ed.). <a href="javascript:if(confirm('https://books.google.com/books?id=le1qAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=le1qAAAAMAAJ'" tppabs="https://books.google.com/books?id=le1qAAAAMAAJ" class="external text external"><i>Ovulation: Stimulation, Suppression, and Detection</i></a>. Lippincott. pp.<span>&nbsp;</span>243–253.</cite></span></li><li id="cite_note-HerrRevesz1970-44"> <span id="mw-reference-text-cite_note-HerrRevesz1970-44" class="mw-reference-text"><cite id="CITEREFHerrReveszMansonJewell1970" class="citation book cs1">Herr, F.; Revesz, C.; Manson, A. J.; Jewell, J. B. (1970). "Biological Properties of Estrogen Sulfates". <i>Chemical and Biological Aspects of Steroid Conjugation</i>. pp.<span>&nbsp;</span>368–408. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-642-49793-3_8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-642-49793-3_8'" tppabs="https://doi.org/10.1007%2F978-3-642-49793-3_8" class="external text external">10.1007/978-3-642-49793-3_8</a>. ISBN<span>&nbsp;</span><bdi>978-3-642-49506-9</bdi>.</cite></span></li><li id="cite_note-pmid29603164-45"> <span id="mw-reference-text-cite_note-pmid29603164-45" class="mw-reference-text"><cite id="CITEREFScottMenonWalsh1980" class="citation journal cs1">Scott WW, Menon M, Walsh PC (April 1980). "Hormonal Therapy of Prostatic Cancer". <i>Cancer</i>. 45 Suppl 7: 1929–1936. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcncr.1980.45.s7.1929  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcncr.1980.45.s7.1929'" tppabs="https://doi.org/10.1002%2Fcncr.1980.45.s7.1929" class="external text external">10.1002/cncr.1980.45.s7.1929</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29603164  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29603164'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29603164" class="external text external">29603164</a>.</cite></span></li><li id="cite_note-pmid8842581-46"> <span id="mw-reference-text-cite_note-pmid8842581-46" class="mw-reference-text"><cite id="CITEREFFotherby1996" class="citation journal cs1">Fotherby K (August 1996). "Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy". <i>Contraception</i>. <b>54</b> (2): 59–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0010-7824%2896%2900136-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0010-7824%2896%2900136-9'" tppabs="https://doi.org/10.1016%2F0010-7824%2896%2900136-9" class="external text external">10.1016/0010-7824(96)00136-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8842581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8842581'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8842581" class="external text external">8842581</a>.</cite></span></li><li id="cite_note-Lobo2007-47"> <span id="mw-reference-text-cite_note-Lobo2007-47" class="mw-reference-text"><cite id="CITEREFRogerio_A._Lobo2007" class="citation book cs1">Rogerio A. Lobo (5 June 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=HB2XO5MhKakC&pg=PA771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=HB2XO5MhKakC&pg=PA771'" tppabs="https://books.google.com/books?id=HB2XO5MhKakC&pg=PA771" class="external text external"><i>Treatment of the Postmenopausal Woman: Basic and Clinical Aspects</i></a>. Academic Press. pp.<span>&nbsp;</span>771–. ISBN<span>&nbsp;</span><bdi>978-0-08-055309-2</bdi>.</cite></span></li><li id="cite_note-NotelovitzKeep2012-48"> <span id="mw-reference-text-cite_note-NotelovitzKeep2012-48" class="mw-reference-text"><cite id="CITEREFM._NotelovitzP.A._van_Keep2012" class="citation book cs1">M. Notelovitz; P.A. van Keep (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=VM0hBQAAQBAJ&pg=PA395  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=VM0hBQAAQBAJ&pg=PA395'" tppabs="https://books.google.com/books?id=VM0hBQAAQBAJ&pg=PA395" class="external text external"><i>The Climacteric in Perspective: Proceedings of the Fourth International Congress on the Menopause, held at Lake Buena Vista, Florida, October 28–November 2, 1984</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>395–. ISBN<span>&nbsp;</span><bdi>978-94-009-4145-8</bdi>.</cite></span></li><li id="cite_note-Seidel1974-49"> <span id="mw-reference-text-cite_note-Seidel1974-49" class="mw-reference-text"><cite id="CITEREFG._E._Seidel1974" class="citation book cs1">G. E. Seidel (1974). <a href="javascript:if(confirm('https://books.google.com/books?id=s21mXv6g5NkC&pg=PA157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=s21mXv6g5NkC&pg=PA157'" tppabs="https://books.google.com/books?id=s21mXv6g5NkC&pg=PA157" class="external text external"><i>Gonadotrophins: Current Research</i></a>. Ardent Media. pp.<span>&nbsp;</span>157–. ISBN<span>&nbsp;</span><bdi>978-0-8422-7205-6</bdi>.</cite></span></li><li id="cite_note-pmid7231202-50"> <span id="mw-reference-text-cite_note-pmid7231202-50" class="mw-reference-text"><cite id="CITEREFPunnonenVilskaGrönroosRauramo1980" class="citation journal cs1">Punnonen R, Vilska S, Grönroos M, Rauramo L (December 1980). "The vaginal absorption of oestrogens in post-menopausal women". <i>Maturitas</i>. <b>2</b> (4): 321–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0378-5122%2880%2990034-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0378-5122%2880%2990034-1'" tppabs="https://doi.org/10.1016%2F0378-5122%2880%2990034-1" class="external text external">10.1016/0378-5122(80)90034-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7231202  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7231202'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7231202" class="external text external">7231202</a>.</cite></span></li><li id="cite_note-WallachHammond1982-51"> <span id="mw-reference-text-cite_note-WallachHammond1982-51" class="mw-reference-text"><cite id="CITEREFWallachHammondMaxson1982" class="citation journal cs1">Wallach, Edward E.; Hammond, Charles B.; Maxson, Wayne S. (1982). "Current status of estrogen therapy for the menopause". <i>Fertility and Sterility</i>. <b>37</b> (1): 5–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0015-0282%2816%2945970-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0015-0282%2816%2945970-4'" tppabs="https://doi.org/10.1016%2FS0015-0282%2816%2945970-4" class="external text external">10.1016/S0015-0282(16)45970-4</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0015-0282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0015-0282'" tppabs="https://www.worldcat.org/issn/0015-0282" class="external text external">0015-0282</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6277697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6277697'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6277697" class="external text external">6277697</a>.</cite></span></li><li id="cite_note-pmid18599548-52"> <span id="mw-reference-text-cite_note-pmid18599548-52" class="mw-reference-text"><cite id="CITEREFBhavnaniTamLu2008" class="citation journal cs1">Bhavnani BR, Tam SP, Lu X (October 2008). "Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta". <i>Endocrinology</i>. <b>149</b> (10): 4857–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fen.2008-0304  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fen.2008-0304'" tppabs="https://doi.org/10.1210%2Fen.2008-0304" class="external text external">10.1210/en.2008-0304</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18599548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18599548'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18599548" class="external text external">18599548</a>.</cite></span></li><li id="cite_note-FeldbergLadd-Taylor2003-53"> <span id="mw-reference-text-cite_note-FeldbergLadd-Taylor2003-53" class="mw-reference-text"><cite id="CITEREFGeorgina_D._FeldbergMolly_Ladd-TaylorAlison_Li2003" class="citation book cs1">Georgina D. Feldberg; Molly Ladd-Taylor; Alison Li (2003). <a href="javascript:if(confirm('https://books.google.com/books?id=CRjtHlq1INcC&pg=PA103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=CRjtHlq1INcC&pg=PA103'" tppabs="https://books.google.com/books?id=CRjtHlq1INcC&pg=PA103" class="external text external"><i>Women, Health and Nation: Canada and the United States Since 1945</i></a>. McGill-Queen's Press - MQUP. pp.<span>&nbsp;</span>103–. ISBN<span>&nbsp;</span><bdi>978-0-7735-2501-6</bdi>.</cite></span></li><li id="cite_note-SchachterMarrian1938-54"> <span id="mw-reference-text-cite_note-SchachterMarrian1938-54" class="mw-reference-text"><cite id="CITEREFSchachterMarrian1938" class="citation journal cs1">Schachter, B.; Marrian, G. F. (1938). "The isolation of estrone sulfate from the urine of pregnant mares". <i>Journal of Biological Chemistry</i>. <b>126</b>: 663–669.</cite></span></li><li id="cite_note-MDD-55"> <span id="mw-reference-text-cite_note-MDD-55" class="mw-reference-text">Jim Kling  October 2000 <a href="javascript:if(confirm('http://pubs.acs.org/subscribe/archive/mdd/v03/i08/html/kling.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pubs.acs.org/subscribe/archive/mdd/v03/i08/html/kling.html'" tppabs="http://pubs.acs.org/subscribe/archive/mdd/v03/i08/html/kling.html" class="external text external">The Strange Case of Premarin</a> Modern Drug Discovery (3):8 46–52</span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://archive.org/details/federalregister37gunit  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://archive.org/details/federalregister37gunit'" tppabs="http://archive.org/details/federalregister37gunit" class="external text external">"Federal register <span>[</span>microform<span>]</span>"</a>. Washington<span>&nbsp;</span>: [Office of the Federal Register, National Archives and Records Service, General Services Administration<span>&nbsp;</span>: Distributed by the Supt. of Docs., U.S. G.P.O.] 3 June 1972 <span>–</span> via Internet Archive.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text">National Institutes of Health Consensus Development Conference Statement. April 2–4, 1984 <a href="javascript:if(confirm('http://consensus.nih.gov/1984/1984Osteoporosis043html.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://consensus.nih.gov/1984/1984Osteoporosis043html.htm'" tppabs="http://consensus.nih.gov/1984/1984Osteoporosis043html.htm" class="external text external">Osteoporosis</a></span></li><li id="cite_note-Woodcock1997-58"> <span id="mw-reference-text-cite_note-Woodcock1997-58" class="mw-reference-text">Food and Drug Administration. May 5, 1997 <a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm168836.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm168836.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm168836.htm" class="external text external">Conjugated Estrogens - Letter from Dr. Janet Woodcock: Approvability of a Synthetic Generic Version of Premarin</a></span></li><li id="cite_note-PanayBriggs2015-59"> <span id="mw-reference-text-cite_note-PanayBriggs2015-59" class="mw-reference-text"><cite id="CITEREFNick_PanayPaula_BriggsGab_Kovacs2015" class="citation book cs1">Nick Panay; Paula Briggs; Gab Kovacs (20 August 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=l0pLCgAAQBAJ&pg=PA118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=l0pLCgAAQBAJ&pg=PA118'" tppabs="https://books.google.com/books?id=l0pLCgAAQBAJ&pg=PA118" class="external text external"><i>Managing the Menopause</i></a>. Cambridge University Press. pp.<span>&nbsp;</span>118–. ISBN<span>&nbsp;</span><bdi>978-1-107-45182-7</bdi>. <q>Premarin (Pregnant Mares Urine) was introduced in Canada in 1941, in the USA in 1942 and in the UK in 1956.</q></cite></span></li><li id="cite_note-ChemIDplus-60"> <span id="mw-reference-text-cite_note-ChemIDplus-60" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://chem.nlm.nih.gov/chemidplus/rn/12126-59-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chem.nlm.nih.gov/chemidplus/rn/12126-59-9'" tppabs="https://chem.nlm.nih.gov/chemidplus/rn/12126-59-9" class="external text external">"ChemIDplus - 12126-59-9 - QTTMOCOWZLSYSV-QWAPEVOJSA-M - Estrogens, conjugated <span>[</span>USP:JAN<span>]</span> - Similar structures search, synonyms, formulas, resource links, and other chemical information"</a>.</cite></span></li><li id="cite_note-HochadelAvorn2007-61"> <span id="mw-reference-text-cite_note-HochadelAvorn2007-61" class="mw-reference-text"><cite id="CITEREFMaryAnne_HochadelJerry_Avorn2007" class="citation book cs1">MaryAnne Hochadel; Jerry Avorn (1 January 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=_OvwGMswS6gC&pg=PA235  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=_OvwGMswS6gC&pg=PA235'" tppabs="https://books.google.com/books?id=_OvwGMswS6gC&pg=PA235" class="external text external"><i>The AARP Guide to Pills: Essential Information on More Than 1,200 Prescription and Nonprescription Medications, Including Generics</i></a>. Sterling Publishing Company Incorporated. pp.<span>&nbsp;</span>235–. ISBN<span>&nbsp;</span><bdi>978-1-4027-4446-4</bdi>.</cite></span></li><li id="cite_note-62"> <span id="mw-reference-text-cite_note-62" class="mw-reference-text"><cite id="CITEREFZiel_HK,_Finkle_WD1975" class="citation journal cs1">Ziel HK, Finkle WD (4 December 1975). "Increased risk of endometrial carcinoma among users of conjugated estrogens". <i>New England Journal of Medicine</i>. <b>293</b> (23): 1167–1170. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM197512042932303  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM197512042932303'" tppabs="https://doi.org/10.1056%2FNEJM197512042932303" class="external text external">10.1056/NEJM197512042932303</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/171569  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/171569'" tppabs="https://pubmed.ncbi.nlm.nih.gov/171569" class="external text external">171569</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFMcDonald1977" class="citation journal cs1">McDonald TW,  et al. (15 March 1977). "Exogenous estrogen and endometrial carcinoma: case-control and incidence study". <i>Am J Obstet Gynecol</i>. <b>127</b> (6): 572–580. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-9378%2877%2990351-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-9378%2877%2990351-9'" tppabs="https://doi.org/10.1016%2F0002-9378%2877%2990351-9" class="external text external">10.1016/0002-9378(77)90351-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/190887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/190887'" tppabs="https://pubmed.ncbi.nlm.nih.gov/190887" class="external text external">190887</a>.</cite></span></li><li id="cite_note-Singer-64"> <span id="mw-reference-text-cite_note-Singer-64" class="mw-reference-text"><cite id="CITEREFNatasha_Singer_and_Duff_Wilson2009" class="citation news cs1">Natasha Singer and Duff Wilson (12 December 2009). <a href="javascript:if(confirm('https://www.nytimes.com/2009/12/13/business/13drug.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2009/12/13/business/13drug.html'" tppabs="https://www.nytimes.com/2009/12/13/business/13drug.html" class="external text external">"Menopause, as Brought to You by Big Pharma"</a>. <i>New York Times</i>.</cite></span></li><li id="cite_note-Brunner-65"> <span id="mw-reference-text-cite_note-Brunner-65" class="mw-reference-text"><cite id="CITEREFBrunner_RL_et_al;_Womens_Health_Initiative_Investigators2005" class="citation journal cs1">Brunner RL et al; Womens Health Initiative Investigators (26 September 2005). <a href="javascript:if(confirm('https://doi.org/10.1001/archinte.165.17.1976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/archinte.165.17.1976'" tppabs="https://doi.org/10.1001/archinte.165.17.1976" class="external text external">"Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized clinical trial"</a>. <i>Archives of Internal Medicine</i>. <b>165</b> (17): 1976–1986. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Farchinte.165.17.1976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchinte.165.17.1976'" tppabs="https://doi.org/10.1001%2Farchinte.165.17.1976" class="external text external">10.1001/archinte.165.17.1976</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16186467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16186467'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16186467" class="external text external">16186467</a>.</cite></span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20071127184549/http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071127184549/http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf'" tppabs="https://web.archive.org/web/20071127184549/http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf" class="external text external">"Earnings Results for the 2006 Fourth Quarter and Full Year"</a> <span class="cs1-format">(PDF)</span> (Press release). Wyeth. Archived from <a href="javascript:if(confirm('http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf'" tppabs="http://www.wyeth.com/irj/servlet/prt/portal/prtroot/com.sap.km.cm.docs/wyeth_xml/home/news/announcements/1170158273391.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 27 November 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2018</span>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120223141331/http://www.theindychannel.com/health/21716786/detail.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120223141331/http://www.theindychannel.com/health/21716786/detail.html'" tppabs="https://web.archive.org/web/20120223141331/http://www.theindychannel.com/health/21716786/detail.html" class="external text external">"Pfizer Statement on Prempro"</a>. Indy News Channel. 24 November 2009. Archived from <a href="javascript:if(confirm('http://www.theindychannel.com/health/21716786/detail.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.theindychannel.com/health/21716786/detail.html'" tppabs="http://www.theindychannel.com/health/21716786/detail.html" class="external text external">the original</a> on 23 February 2012.</cite></span></li><li id="cite_note-Bloomberg_2010-68"> <span id="mw-reference-text-cite_note-Bloomberg_2010-68" class="mw-reference-text"><cite id="CITEREFJef_Feeley2010" class="citation news cs1">Jef Feeley (24 February 2010). "Pfizer wins trial over claim Prempro caused cancer". Bloomberg.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.bloomberg.com/news/2010-12-03/pfizer-properly-warned-about-prempro-health-risks-jury-finds.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/news/2010-12-03/pfizer-properly-warned-about-prempro-health-risks-jury-finds.html'" tppabs="https://www.bloomberg.com/news/2010-12-03/pfizer-properly-warned-about-prempro-health-risks-jury-finds.html" class="external text external">"Pfizer properly warned about Prempro risks, jury finds"</a>. 3 December 2010.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.law.com/jsp/article.jsp?id=1202444500915  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.law.com/jsp/article.jsp?id=1202444500915'" tppabs="http://www.law.com/jsp/article.jsp?id=1202444500915" class="external text external">"Legal Intelligencer: Philadelphia jury returns defense verdict in HRT case, Amaris Elliott Engel"</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite id="CITEREFNews2004" class="citation web cs1">News, Keith Morrison NBC (19 January 2004). <a href="javascript:if(confirm('http://www.nbcnews.com/id/3995076/ns/dateline_nbc/t/hrt-horses/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nbcnews.com/id/3995076/ns/dateline_nbc/t/hrt-horses/'" tppabs="http://www.nbcnews.com/id/3995076/ns/dateline_nbc/t/hrt-horses/" class="external text external">"The HRT horses"</a>. <i>msnbc.com</i>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFBhavnani1988" class="citation journal cs1">Bhavnani, Bhagu R. (1988). "The Saga of the Ring B Unsaturated Equine Estrogens*". <i>Endocrine Reviews</i>. <b>9</b> (4): 396–416. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fedrv-9-4-396  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fedrv-9-4-396'" tppabs="https://doi.org/10.1210%2Fedrv-9-4-396" class="external text external">10.1210/edrv-9-4-396</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0163-769X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0163-769X'" tppabs="https://www.worldcat.org/issn/0163-769X" class="external text external">0163-769X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3065072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3065072'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3065072" class="external text external">3065072</a>.</cite></li>
<li><cite id="CITEREFAnsbacher1993" class="citation journal cs1">Ansbacher R (April 1993). "Bioequivalence of conjugated estrogen products". <i>Clin Pharmacokinet</i>. <b>24</b> (4): 271–4. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-199324040-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-199324040-00001'" tppabs="https://doi.org/10.2165%2F00003088-199324040-00001" class="external text external">10.2165/00003088-199324040-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8387902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8387902'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8387902" class="external text external">8387902</a>.</cite></li>
<li><cite id="CITEREFO'Connell1995" class="citation journal cs1">O'Connell MB (September 1995). "Pharmacokinetic and pharmacologic variation between different estrogen products". <i>J Clin Pharmacol</i>. <b>35</b> (9 Suppl): 18S–24S. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1552-4604.1995.tb04143.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1552-4604.1995.tb04143.x'" tppabs="https://doi.org/10.1002%2Fj.1552-4604.1995.tb04143.x" class="external text external">10.1002/j.1552-4604.1995.tb04143.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8530713  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8530713'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8530713" class="external text external">8530713</a>.</cite></li>
<li><cite id="CITEREFEgarterGeurtsBoschitschSpeiser1996" class="citation journal cs1">Egarter C, Geurts P, Boschitsch E, Speiser P, Huber J (April 1996). "The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women". <i>Acta Obstet Gynecol Scand</i>. <b>75</b> (4): 386–93. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F00016349609033337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F00016349609033337'" tppabs="https://doi.org/10.3109%2F00016349609033337" class="external text external">10.3109/00016349609033337</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8638462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8638462'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8638462" class="external text external">8638462</a>.</cite></li>
<li><cite id="CITEREFBhavnani1998" class="citation journal cs1">Bhavnani BR (January 1998). "Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism". <i>Proc. Soc. Exp. Biol. Med</i>. <b>217</b> (1): 6–16. doi:<a href="javascript:if(confirm('https://doi.org/10.3181%2F00379727-217-44199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3181%2F00379727-217-44199'" tppabs="https://doi.org/10.3181%2F00379727-217-44199" class="external text external">10.3181/00379727-217-44199</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9421201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9421201'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9421201" class="external text external">9421201</a>.</cite></li>
<li><cite id="CITEREFGruberHuber1999" class="citation journal cs1">Gruber DM, Huber JC (December 1999). "Conjugated estrogens--the natural SERMs". <i>Gynecol. Endocrinol</i>. 13 Suppl 6: 9–12. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10862263  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10862263'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10862263" class="external text external">10862263</a>.</cite></li>
<li><cite id="CITEREFCampagnoliAmbroggioBigliaSismondi1999" class="citation journal cs1">Campagnoli C, Ambroggio S, Biglia N, Sismondi P (December 1999). "Conjugated estrogens and breast cancer risk". <i>Gynecol. Endocrinol</i>. 13 Suppl 6: 13–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10862264  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10862264'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10862264" class="external text external">10862264</a>.</cite></li>
<li><cite id="CITEREFBhavnani2003" class="citation journal cs1">Bhavnani BR (June 2003). "Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's". <i>J. Steroid Biochem. Mol. Biol</i>. <b>85</b> (2–5): 473–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0960-0760%2803%2900220-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0960-0760%2803%2900220-6'" tppabs="https://doi.org/10.1016%2FS0960-0760%2803%2900220-6" class="external text external">10.1016/S0960-0760(03)00220-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12943738  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12943738'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12943738" class="external text external">12943738</a>.</cite></li>
<li><cite id="CITEREFOrtmannTraupeVetterBarton2004" class="citation journal cs1">Ortmann J, Traupe T, Vetter W, Barton M (May 2004). "[Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate]". <i>Praxis</i> (in German). <b>93</b> (21): 904–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1024%2F0369-8394.93.21.904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1024%2F0369-8394.93.21.904'" tppabs="https://doi.org/10.1024%2F0369-8394.93.21.904" class="external text external">10.1024/0369-8394.93.21.904</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15216975  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15216975'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15216975" class="external text external">15216975</a>.</cite></li>
<li><cite class="citation journal cs1">Kuhl H (2005). <a href="javascript:if(confirm('http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf'" tppabs="http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf" class="external text external">"Pharmacology of estrogens and progestogens: influence of different routes of administration"</a> <span class="cs1-format">(PDF)</span>. <i>Climacteric</i>. 8 Suppl 1: 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>.</cite></li>
<li><cite id="CITEREFKurabayashi2007" class="citation journal cs1">Kurabayashi T (November 2007). "[New evidence of conjugated estrogen and 17beta-estradiol for treatment and prevention of osteoporosis]". <i>Nippon Rinsho</i> (in Japanese). 65 Suppl 9: 369–73. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18161134  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18161134'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18161134" class="external text external">18161134</a>.</cite></li>
<li><cite id="CITEREFLambaKaurAdapaShah2013" class="citation journal cs1">Lamba G, Kaur H, Adapa S, Shah D, Malhotra BK, Rafiyath SM, Thakar K, Fernandez AC (June 2013). "Use of conjugated estrogens in life-threatening gastrointestinal bleeding in hemodialysis patients--a review". <i>Clin. Appl. Thromb. Hemost</i>. <b>19</b> (3): 334–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F1076029612437575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F1076029612437575'" tppabs="https://doi.org/10.1177%2F1076029612437575" class="external text external">10.1177/1076029612437575</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22411999  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22411999'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22411999" class="external text external">22411999</a>.</cite></li>
<li><cite id="CITEREFMirkinKommPickar2014" class="citation journal cs1">Mirkin S, Komm BS, Pickar JH (January 2014). "Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data". <i>Expert Opin Drug Saf</i>. <b>13</b> (1): 45–56. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740338.2013.824965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740338.2013.824965'" tppabs="https://doi.org/10.1517%2F14740338.2013.824965" class="external text external">10.1517/14740338.2013.824965</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23919270  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23919270'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23919270" class="external text external">23919270</a>.</cite></li>
<li><cite class="citation journal cs1">Bhavnani BR, Stanczyk FZ (July 2014). "Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action". <i>J. Steroid Biochem. Mol. Biol</i>. <b>142</b>: 16–29. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jsbmb.2013.10.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jsbmb.2013.10.011'" tppabs="https://doi.org/10.1016%2Fj.jsbmb.2013.10.011" class="external text external">10.1016/j.jsbmb.2013.10.011</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24176763  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24176763'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24176763" class="external text external">24176763</a>.</cite></li>
<li><cite id="CITEREFMattisonKaryakinaGoodmanLaKind2014" class="citation journal cs1">Mattison DR, Karyakina N, Goodman M, LaKind JS (2014). "Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps". <i>Crit. Rev. Toxicol</i>. <b>44</b> (8): 696–724. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F10408444.2014.930813  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F10408444.2014.930813'" tppabs="https://doi.org/10.3109%2F10408444.2014.930813" class="external text external">10.3109/10408444.2014.930813</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25099693  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25099693'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25099693" class="external text external">25099693</a>.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/estrogens%2C%20conjugated  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/estrogens%2C%20conjugated'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/estrogens%2C%20conjugated" class="external text external">"Estrogens, conjugated"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/steroidal%20estrogens  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/steroidal%20estrogens'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/steroidal%20estrogens" class="external text external">"Steroidal estrogens"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20081218203608/http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081218203608/http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2554'" tppabs="https://web.archive.org/web/20081218203608/http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2554" class="external text external">WHI Follow-up Study Confirms Health Risks of Long-Term Combination Hormone Therapy Outweigh Benefits for Postmenopausal Women</a> NIH press release, March 4, 2008</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Estradiol" style="padding:3px"><table class="nowraplinks mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estradiol" style="font-size:114%;margin:0 4em"><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Topics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol (as a hormone)</a></li>
<li>Estradiol (as a medication)</li>
<li>Pharmacodynamics of estradiol</li>
<li>Pharmacokinetics of estradiol</li>
<li><a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">Estrogen (as a hormone)</a></li>
<li>Estrogen (as a medication)</li>
<li>Menopausal hormone therapy</li>
<li>Transgender hormone therapy (male-to-female)</li>
<li>Estradiol-containing birth control pill</li>
<li>Combined injectable birth control</li>
<li>High-dose estrogen</li>
<li>Hydroxylation of estradiol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Esters</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Estrogen ester</li>
<li>Estradiol ester</li>
<li>Estradiol acetate</li>
<li>Estradiol benzoate</li>
<li>Estradiol benzoate butyrate</li>
<li>Estradiol cypionate</li>
<li>Estradiol dipropionate</li>
<li>Estradiol enantate</li>
<li>Estradiol undecylate</li>
<li>Estradiol valerate</li>
<li>Polyestradiol phosphate</li>
<li>Estramustine phosphate (estradiol normustine phosphate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Related</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Estrone</li>
<li>Estriol</li>
<li>Estetrol</li>
<li>Ethinylestradiol</li>
<li>Conjugated estrogens</li>
<li>Esterified estrogens</li>
<li>Estrone sulfate</li>
<li>Estropipate (piperazine estrone sulfate)</li></ul>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogens_and_antiestrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogens_and_antiestrogens" style="font-size:114%;margin:0 4em">Estrogens and antiestrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Estrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li>Certain androgens/anabolic steroids (e.g., testosterone, testosterone esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone, nandrolone esters) (via estrogenic metabolites)</li>
<li>Certain progestins (e.g., <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>, noretynodrel, <a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">etynodiol diacetate</a>, tibolone)</li>
<li>Clomestrone</li>
<li>Cloxestradiol acetate</li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Epiestriol</li>
<li>Epimestrol</li>
<li>Esterified estrogens</li>
<li>Estetrol<sup>†</sup></li>
<li>Estradiol</li>
<li>Estradiol esters (e.g., estradiol acetate, estradiol benzoate, estradiol cypionate, estradiol enanthate, estradiol undecylate, estradiol valerate, polyestradiol phosphate, estradiol ester mixtures (Climacteron))</li>
<li>Estramustine phosphate</li>
<li>Estriol</li>
<li>Estriol esters (e.g., estriol succinate, polyestriol phosphate)</li>
<li>Estrogenic substances</li>
<li>Estrone</li>
<li>Estrone esters
<ul><li>Estrone sulfate</li>
<li>Estropipate (piperazine estrone sulfate)</li></ul></li>
<li>Ethinylestradiol<sup>#</sup>
<ul><li>Ethinylestradiol sulfonate</li></ul></li>
<li>Hydroxyestrone diacetate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Nilestriol</li>
<li>Prasterone (dehydroepiandrosterone; DHEA)
<ul><li>Prasterone enanthate</li>
<li>Prasterone sulfate</li></ul></li>
<li>Promestriene</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Benzestrol</li>
<li>Bifluranol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol (stilbestrol)</a></li>
<li>Diethylstilbestrol esters/ethers
<ul><li>Dimestrol (diethylstilbestrol dimethyl ether)</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Mestilbol (diethylstilbestrol monomethyl ether)</li></ul></li>
<li>Doisynoestrol (fenocycline)</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol (promethestrol)
<ul><li>Methestrol dipropionate (promethestrol dipropionate)</li></ul></li>
<li>Paroxypropione</li>
<li>Quadrosilan</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiandrogens (e.g., <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr> (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <abbr>FSH</abbr>, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiestrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> antagonists<br>(incl. <abbr>SERMs</abbr>/<abbr>SERDs</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acolbifene<sup>†</sup></li>
<li>Anordrin</li>
<li>Bazedoxifene</li>
<li>Broparestrol</li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a><sup>#</sup></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li>Enclomifene<sup>†</sup></li>
<li>Epitiostanol</li>
<li>Lasofoxifene</li>
<li>Mepitiostane</li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a><sup>#</sup></li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li></ul>

<ul><li><i>Exclusively antagonistic:</i> <a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Aromatase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>First-generation:</i> <a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a></li></ul>

<ul><li><i>Second-generation:</i> Fadrozole</li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li></ul>

<ul><li><i>Third-generation:</i> <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Letrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Letrozole" title="Letrozole">Letrozole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens/anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>, testosterone esters, nandrolone esters, <a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>, <a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">fluoxymesterone</a>)</li>
<li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>, <a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">goserelin</a>)</li>
<li><abbr>GnRH</abbr> antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>, elagolix)</li>
<li>Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, hydroxyprogesterone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Mixed mechanism of action:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li></ul>

<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Estrogen receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of estrogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogen_receptor_modulators" style="font-size:114%;margin:0 4em">Estrogen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol</li>
<li>3α-Androstanediol</li>
<li><span class="new">3α,5α-Dihydrolevonorgestrel</span></li>
<li><span class="new">3β,5α-Dihydrolevonorgestrel</span></li>
<li>3α-Hydroxytibolone</li>
<li>3β-Hydroxytibolone</li>
<li>3β-Androstanediol</li>
<li><a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">4-Androstenedione</a></li>
<li>4-Fluoroestradiol</li>
<li>4-Hydroxyestradiol</li>
<li>4-Hydroxyestrone</li>
<li>4-Methoxyestradiol</li>
<li>4-Methoxyestrone</li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">5-Androstenediol</a></li>
<li>7-Oxo-DHEA</li>
<li>7α-Hydroxy-DHEA</li>
<li>7α-Methylestradiol</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>8,9-Dehydroestradiol</li>
<li>8,9-Dehydroestrone</li>
<li>8β-VE2</li>
<li>10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)</li>
<li>11β-Chloromethylestradiol</li>
<li>11β-Methoxyestradiol</li>
<li>15α-Hydroxyestradiol</li>
<li>16-Ketoestradiol</li>
<li>16-Ketoestrone</li>
<li>16α-Fluoroestradiol</li>
<li>16α-Hydroxy-DHEA</li>
<li>16α-Hydroxyestrone</li>
<li>16α-Iodoestradiol</li>
<li>16α-LE2</li>
<li>16β-Hydroxyestrone</li>
<li>16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)</li>
<li>17α-Estradiol (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">alfatradiol</a>)</li>
<li>17α-Dihydroequilenin</li>
<li>17α-Dihydroequilin</li>
<li>17α-Epiestriol (16α-hydroxy-17α-estradiol)</li>
<li>17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>17β-Dihydroequilenin</li>
<li>17β-Dihydroequilin</li>
<li>17β-Methyl-17α-dihydroequilenin</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Alestramustine</li>
<li>Almestrone</li>
<li>Anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone (methandrostenolone), <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, many others; via estrogenic metabolites)</li>
<li>Atrimustine</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Butolame</li>
<li>Clomestrone</li>
<li>Cloxestradiol
<ul><li>Cloxestradiol acetate</li></ul></li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Cyclodiol</li>
<li>Cyclotriol</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA-S</a></li>
<li><i>ent</i>-Estradiol</li>
<li>Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)</li>
<li>Epimestrol</li>
<li><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></li>
<li><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></li>
<li>ERA-63 (ORG-37663)</li>
<li>Esterified estrogens</li>
<li>Estetrol</li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a>
<ul><li>Estradiol esters</li>
<li>Lipoidal estradiol</li>
<li>Polyestradiol phosphate</li></ul></li>
<li><a href="Estramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Estramustine" title="Estramustine">Estramustine</a></li>
<li>Estramustine phosphate</li>
<li>Estrapronicate</li>
<li>Estrazinol</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a>
<ul><li>Estriol esters</li>
<li>Polyestriol phosphate</li></ul></li>
<li>Estrofurate</li>
<li>Estrogenic substances</li>
<li>Estromustine</li>
<li><a href="Estrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrone" title="Estrone">Estrone</a>
<ul><li>Estrone esters</li>
<li>Estrone methyl ether</li>
<li>Estropipate</li></ul></li>
<li>Etamestrol (eptamestrol)</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li>Ethinylestradiol
<ul><li>Ethinylestradiol 3-benzoate</li>
<li>Ethinylestradiol sulfonate</li></ul></li>
<li>Ethinylestriol</li>
<li>Ethylestradiol</li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Hexolame</li>
<li>Hippulin</li>
<li>Hydroxyestrone diacetate</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Mytatrienediol</li>
<li>Nilestriol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Noretynodrel</li>
<li>Orestrate</li>
<li>Pentolame</li>
<li>Prodiame</li>
<li>Prolame</li>
<li>Promestriene</li>
<li>RU-16117</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li>
<li>Tibolone</li></ul>

<ul><li><i>Nonsteroidal:</i> (R,R)-THC</li>
<li>(S,S)-THC</li>
<li>2,8-DHHHC</li>
<li><span class="new">β-LGND1</span></li>
<li>β-LGND2 (GTx-878)</li>
<li><span class="new">AC-186</span></li>
<li>Allenestrol</li>
<li>Allenolic acid</li>
<li>Benzestrol</li>
<li>Bifluranol</li>
<li>Bisdehydrodoisynolic acid</li>
<li>Butestrol</li>
<li>Carbestrol</li>
<li>D-15414</li>
<li>DCW234</li>
<li>Diarylpropionitrile</li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a>
<ul><li>Diethylstilbestrol esters</li></ul></li>
<li>Dimestrol (dianisylhexene)</li>
<li>Dimethylstilbestrol</li>
<li>Doisynoestrol (fenocycline)</li>
<li>Doisynolic acid</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>ERB-196 (WAY-202196)</li>
<li>Erteberel (SERBA-1, LY-500307)</li>
<li>Estrobin (DBE)</li>
<li>Fenestrel</li>
<li>FERb 033</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Furostilbestrol (diethylstilbestrol difuroate)</li>
<li>GTx-758</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li>ICI-85966 (Stilbostat)</li>
<li>M2613</li>
<li><i>meso</i>-Butestrol</li>
<li><i>meso</i>-Hexestrol</li>
<li>Mestilbol</li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol</li>
<li>Methestrol dipropionate</li>
<li>Paroxypropione</li>
<li>Pentafluranol</li>
<li>Phenestrol</li>
<li>Prinaberel (ERB-041, WAY-202041)</li>
<li>Propylpyrazoletriol</li>
<li>Quadrosilan</li>
<li><span class="new">SC-3296</span></li>
<li>SC-4289</li>
<li>SERBA-2</li>
<li>SKF-82,958</li>
<li>Terfluranol</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li>Triphenyliodoethylene</li>
<li>Triphenylmethylethylene (triphenylpropene)</li>
<li>WAY-166818</li>
<li><span class="new">WAY-169916</span></li>
<li>WAY-200070</li>
<li>WAY-204688 (SIM-688)</li>
<li>WAY-214156</li></ul>

<ul><li><i>Unknown/unsorted:</i> ERB-26</li>
<li>ERA-45</li>
<li>ERB-79</li>
<li>ZK-283197</li></ul>

<ul><li><i>Xenoestrogens:</i> <a href="Anise.htm" tppabs="https://ptable.com/wiki/compounds/A/Anise" title="Anise">Anise</a>-related (e.g., <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a>, anol, dianethole, dianol, photoanethole)</li>
<li>Chalconoids (e.g., <a href="Isoliquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoliquiritigenin" title="Isoliquiritigenin">isoliquiritigenin</a>, <a href="Phloretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phloretin" title="Phloretin">phloretin</a>, <a href="Phlorizin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phlorizin" title="Phlorizin">phlorizin (phloridzin)</a>, wedelolactone)</li>
<li>Coumestans (e.g., <a href="Coumestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumestrol" title="Coumestrol">coumestrol</a>, psoralidin)</li>
<li><a href="Flavonoid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavonoid" title="Flavonoid">Flavonoids</a> (incl. 7,8-DHF, 8-prenylnaringenin, <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">apigenin</a>, <a href="Baicalein.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalein" title="Baicalein">baicalein</a>, <a href="Baicalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalin" title="Baicalin">baicalin</a>, <a href="Biochanin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Biochanin_A" title="Biochanin A">biochanin A</a>, <a href="Calycosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Calycosin" title="Calycosin">calycosin</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">catechin</a>, <a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">daidzein</a>, daidzin, ECG, <a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">epicatechin</a>, <a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">equol</a>, <a href="Formononetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Formononetin" title="Formononetin">formononetin</a>, glabrene, glabridin, <a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">genistein</a>, <a href="Genistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistin" title="Genistin">genistin</a>, <a href="Glycitein.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycitein" title="Glycitein">glycitein</a>, <a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">kaempferol</a>, <a href="Liquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Liquiritigenin" title="Liquiritigenin">liquiritigenin</a>, mirificin, <a href="Myricetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Myricetin" title="Myricetin">myricetin</a>, <a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">naringenin</a>, <span class="new">penduletin</span>, pinocembrin, <a href="Prunetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prunetin" title="Prunetin">prunetin</a>, puerarin, <a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">quercetin</a>, tectoridin, tectorigenin)</li>
<li>Lavender oil</li>
<li>Lignans (e.g., enterodiol, enterolactone, nyasol (<i>cis</i>-hinokiresinol))</li>
<li>Metalloestrogens (e.g., <a href="Cadmium.htm" tppabs="https://ptable.com/wiki/compounds/A/Cadmium" title="Cadmium">cadmium</a>)</li>
<li>Pesticides (e.g., alternariol, <a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">endosulfan</a>, <a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">fenarimol</a>, HPTE, <a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">methiocarb</a>, <a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">methoxychlor</a>, <a href="Triclocarban.htm" tppabs="https://ptable.com/wiki/compounds/A/Triclocarban" title="Triclocarban">triclocarban</a>, triclosan)</li>
<li>Phytosteroids (e.g., <a href="Digitoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digitoxin" title="Digitoxin">digitoxin</a> (digitalis), <a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">diosgenin</a>, guggulsterone)</li>
<li><a href="Phytosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytosterol" title="Phytosterol">Phytosterols</a> (e.g., β-sitosterol, <a href="Campesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Campesterol" title="Campesterol">campesterol</a>, <a href="Stigmasterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stigmasterol" title="Stigmasterol">stigmasterol</a>)</li>
<li>Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, <a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">zearalenone</a>, <a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">zeranol (α-zearalanol)</a>, taleranol (teranol, β-zearalanol))</li>
<li>Steroid-like (e.g., deoxymiroestrol, miroestrol)</li>
<li>Stilbenoids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">resveratrol</a>, <a href="Rhaponticin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rhaponticin" title="Rhaponticin">rhaponticin</a>)</li>
<li>Synthetic xenoestrogens (e.g., alkylphenols, <a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">bisphenols</a> (e.g., <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">BPA</a>, BPF, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">BPS</a>), DDT, parabens, <a href="Polybrominated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polybrominated_biphenyl" title="Polybrominated biphenyl">PBBs</a>, PHBA, phthalates, <a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a>)</li>
<li>Others (e.g., agnuside, <span class="new">rotundifuran</span>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SERMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">2-Phenylbenzofuran</span></li>
<li><span class="new">2-Phenylbenzothiophene</span></li>
<li>4'-Hydroxynorendoxifen</li>
<li>27-Hydroxycholesterol</li>
<li>Acefluranol</li>
<li>Acolbifene</li>
<li>Afimoxifene</li>
<li>Anordiol</li>
<li>Anordrin</li>
<li>Arzoxifene</li>
<li>Bazedoxifene</li>
<li>Brilanestrant</li>
<li>Broparestrol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></li>
<li>Clomifenoxide</li>
<li><span class="new">CN-55945-27</span></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li><span class="new">D-15413</span></li>
<li>Desmethylchlorotrianisene</li>
<li>Droloxifene</li>
<li>Elacestrant</li>
<li>Enclomifene</li>
<li>Endoxifen</li>
<li>Etacstil (GW-5638, DPC-974)</li>
<li>Ethamoxytriphetol (MER-25)</li>
<li>Femarelle</li>
<li>Fispemifene</li>
<li><span class="new">GW-7604</span></li>
<li><span class="new">ICI-55548</span></li>
<li><a href="Idoxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxifene" title="Idoxifene">Idoxifene</a></li>
<li>Lasofoxifene</li>
<li>Levormeloxifene</li>
<li>LN-1643</li>
<li>LN-2299</li>
<li><span class="new">LY-117018</span></li>
<li>Menerba</li>
<li>Miproxifene</li>
<li>Miproxifene phosphate</li>
<li><span class="new">MRL-37</span></li>
<li>Nafoxidine</li>
<li>Nitromifene</li>
<li>NNC 45-0095</li>
<li><span class="new">NNC 45-0320</span></li>
<li><span class="new">NNC 45-0781</span></li>
<li><span class="new">NNC 45-1506</span></li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li>Panomifene</li>
<li>Pipendoxifene</li>
<li><span class="new">Promensil</span></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li>Rimostil (P-081)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li><span class="new">SS1010</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>TAS-108 (SR-16234)</li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li>
<li>Trioxifene</li>
<li><span class="new">TZE-5323</span></li>
<li><span class="new">U-11555A</span></li>
<li><span class="new">U-11634</span></li>
<li><span class="new">Y-134</span></li>
<li>Zindoxifene</li>
<li>Zuclomifene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(R,R)-THC</li>
<li>7β-Hydroxy-DHEA</li>
<li><span class="new">Chloroindazole</span></li>
<li>Cytestrol acetate</li>
<li><span class="new">EM-800 (SCH-57050)</span></li>
<li>Epitiostanol</li>
<li><span class="new">ERA-90</span></li>
<li><span class="new">ERB-88</span></li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><a href="Glyceollin.htm" tppabs="https://ptable.com/wiki/compounds/A/Glyceollin" title="Glyceollin">Glyceollins</a> (I, <span class="new">II</span>, III, <span class="new">IV</span>)</li>
<li>ICI-164384</li>
<li><span class="new">MDL-101906</span></li>
<li>Mepitiostane</li>
<li>Methylepitiostanol</li>
<li>Methylpiperidinopyrazole</li>
<li>MIBE</li>
<li><span class="new">Oxabicycloheptene sulfonate</span></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>PHTPP</li>
<li>Prochloraz</li>
<li><span class="new">RU-39411</span></li>
<li><span class="new">RU-58668</span></li>
<li><span class="new">SS1020</span></li>
<li>TAS-108 (SR-16234)</li>
<li>ZB716</li>
<li><span class="new">ZK-164015</span></li>
<li><span class="new">ZK-191703</span></li></ul>

<ul><li><i>Coregulator-binding modulators:</i> ERX-11</li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>7β-Hydroxyepiandrosterone</li>
<li>Afimoxifene (4-hydroxytamoxifen)</li>
<li><a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">Aldosterone</a></li>
<li><a href="Atrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atrazine" title="Atrazine">Atrazine</a></li>
<li><a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>DDT (p,p'-DDT, <span class="new">o',p'-DDE</span>)</li>
<li>Diarylpropionitrile</li>
<li><a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">Equol</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li>Ethinylestradiol</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><span class="new">G-1</span></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><span class="new">GPER-L1</span></li>
<li><span class="new">GPER-L2</span></li>
<li>Hydroxytyrosol</li>
<li><a href="Kepone.htm" tppabs="https://ptable.com/wiki/compounds/A/Kepone" title="Kepone">Kepone</a></li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li><a href="Nicotinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="Nonylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nonylphenol" title="Nonylphenol">Nonylphenol</a></li>
<li><a href="Oleuropein.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleuropein" title="Oleuropein">Oleuropein</a></li>
<li><a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a> (<span class="new">2,2',5'-PCB-4-OH</span>)</li>
<li>Propylpyrazoletriol</li>
<li><a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">Quercetin</a></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">Resveratrol</a></li>
<li><span class="new">STX</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Tectoridin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CCL18</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a></li>
<li><span class="new">G-15</span></li>
<li><span class="new">G-36</span></li>
<li>MIBE</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Unknown</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li>
<li><a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">Zearalenone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of estrogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2018-02-20" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Premarin&oldid=826627613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Premarin&oldid=826627613'" tppabs="https://en.wikipedia.org/wiki/?title=Premarin&oldid=826627613">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>



</body></html>